Section 1: Introduction to Microbiology |
|
History of Microbiology |
40:36 |
| |
Intro |
0:00 | |
| |
Overview of Microbiology |
0:35 | |
| |
| What is Microbiology? |
0:39 | |
| |
| History of Microbiology |
0:47 | |
| |
What is Microbiology? |
3:11 | |
| |
| Study of Biology of Pathogen |
4:05 | |
| |
| Study of Biology of Vector |
4:13 | |
| |
| Biology of Human Host |
4:28 | |
| |
Microbiology |
6:32 | |
| |
| Study of Microorganisms |
6:35 | |
| |
| Includes Viruses, Small Macroscopic Organisms, and Parasites |
7:48 | |
| |
| Microorganisms are Responsible for Cycling the Chemical Elements Essential for Life |
9:32 | |
| |
| Produce More Energy Through Photosynthesis Than Plants |
10:00 | |
| |
| 90% of Cells in Our Body are Microbes |
11:20 | |
| |
Important Discoveries in Microbiology |
11:29 | |
| |
| Anton Van Leeuwenhoek |
11:48 | |
| |
| Invented of the Microscope |
11:59 | |
| |
What Was Leeuwenhoek's World? |
12:47 | |
| |
The First Smallpox Vaccination: Jenner 1796 |
13:25 | |
| |
| Jenner Invented the First Vaccine |
13:35 | |
| |
| Protected from Smallpox |
13:58 | |
| |
Edward Jenner and Vaccination |
14:49 | |
| |
| Cowpox Virus |
15:25 | |
| |
| Material Used for Vaccine Probably Contained Cowpox Virus |
15:46 | |
| |
| Inoculate James Phipps by Taking Pus from the Lesions on the Hands of a Diary Maid |
16:20 | |
| |
Louis Pasteur and Theory of Spontaneous Generation |
17:58 | |
| |
| Pasteur's S-Shaped Flask Kept Microbes Out but Let Air In |
18:04 | |
| |
| Disproved Theory of Spontaneous Generation |
18:20 | |
| |
Fermentation, Pasteurization, and Vaccination: Louis Pasteur |
19:53 | |
| |
| Fermentation |
19:54 | |
| |
| Pasteurizing |
20:14 | |
| |
| Vaccination |
20:56 | |
| |
The Germ Theory of Disease: Robert Koch |
21:13 | |
| |
| Koch's Postulates |
21:47 | |
| |
Koch's Postulates |
23:13 | |
| |
| Procedure to Determine Criteria to Establish Casual Relationship Between a Microbe and Disease |
23:34 | |
| |
A Fortunate Accident: Antibiotics |
25:40 | |
| |
| Alexander Fleming Discovered the First Antibiotic |
25:55 | |
| |
Summary of Important Discoveries |
27:12 | |
| |
| Ability to Visualize Microorganisms |
27:49 | |
| |
| Vaccination |
28:59 | |
| |
| Fermentation, Pasteurization and Vaccination from Rabies |
29:21 | |
| |
| Germ Theory of Disease |
29:42 | |
| |
| Antibiotics |
30:08 | |
| |
Example 1 |
31:36 | |
| |
Example 2 |
32:02 | |
| |
Example 3 |
33:56 | |
| |
Example 4 |
37:53 | |
| |
Example 5 |
38:57 | |
|
Laboratory Testing & Visualization |
44:19 |
| |
Intro |
0:00 | |
| |
Laboratory Testing and Visualization |
0:37 | |
| |
| Serology |
1:09 | |
| |
| Visualization: Types of Microscopes |
1:32 | |
| |
A Clinical Microbiology Lab Report Form |
1:57 | |
| |
Generalized Tests for Microorganisms |
2:36 | |
| |
| Morphological Characteristics |
2:44 | |
| |
| Differential Staining |
3:00 | |
| |
| Biochemical Tests |
3:45 | |
| |
A Clinical Microbiology Lab Report Form |
4:19 | |
| |
Serology |
6:38 | |
| |
| Detect Levels of Antibodies |
6:46 | |
| |
| Blood Serum |
7:43 | |
| |
| Recent of Past Infection |
7:59 | |
| |
| Differentiate Different Strains |
9:39 | |
| |
Example of Serology Testing for HBV |
10:02 | |
| |
Direct Agglutination Testing |
12:52 | |
| |
| Visual Test |
13:08 | |
| |
| Positive Results |
13:16 | |
| |
| Antibodies Sufficient in Level |
14:13 | |
| |
ELISA Test |
15:56 | |
| |
| Sandwich ELISA |
16:39 | |
| |
Western Blot |
18:56 | |
| |
| Proteins are Positioned on the Filter so Antibodies Can Bind to the Antigens |
19:09 | |
| |
| Filter is Then Washed with Patient's Serum |
19:27 | |
| |
| Positive Test for Particular Microorganisms |
20:04 | |
| |
Flow Cytometry |
21:09 | |
| |
| Used to Identify Bacteria Without Culturing the Bacteria |
21:17 | |
| |
| Moving Fluid Containing Bacteria is Forced Through Small Opening |
22:03 | |
| |
| Differences in Electrical Conductivity Between the Cells are Detected |
22:17 | |
| |
| Results Distinguishing Three Different Species of Microorganisms |
22:56 | |
| |
Genetic Testing: DNA Fingerprinting |
23:49 | |
| |
| Way to Specify and Differentiate Bacteria |
25:36 | |
| |
| Some Produce Taxon |
25:47 | |
| |
| Used as a Proxy for Microbial Cell Abundance |
26:13 | |
| |
| Detailed Figure |
26:43 | |
| |
Pattern Matching to Determine Bacterial Strain |
27:22 | |
| |
| Example |
28:00 | |
| |
| Picture of That |
28:04 | |
| |
Instruments to Visualize Microorganisms |
29:36 | |
| |
Light Microscope |
30:22 | |
| |
| Image |
31:18 | |
| |
Darkfield Microscopy |
31:44 | |
| |
| An Illumination Technique Used to Enhance the Contrast in Unstained Samples |
31:51 | |
| |
| How It Works |
32:01 | |
| |
Planaria in Pond Water |
32:19 | |
| |
Electron Microscope |
32:55 | |
| |
| Uses Electron Beam to Illuminate a Specimen and Produce a Magnified Image |
33:23 | |
| |
| Electron Microscopy |
33:34 | |
| |
| Electron Microscope Image |
34:23 | |
| |
Atomic Force Microscope |
34:41 | |
| |
| Manipulates Matter at the Nanoscale |
35:09 | |
| |
| Atomic Force Microscopy Image |
35:37 | |
| |
Atomic Force Imaging |
35:54 | |
| |
Instruments to Visualize Microorganisms |
37:02 | |
| |
| Light Microscopes |
37:18 | |
| |
Example 1 |
37:28 | |
| |
Example 2 |
40:19 | |
| |
Example 3 |
40:57 | |
| |
Example 4 |
42:13 | |
| |
Example 5 |
42:35 | |
|
Present Day Importance of Microbiology |
43:48 |
| |
Intro |
0:00 | |
| |
Two Important Topic Area in Microbiology |
0:41 | |
| |
Gut Microbiome |
1:21 | |
| |
| A Forgotten Organ |
1:25 | |
| |
| Colonization of the Gut Begins at Birth |
2:34 | |
| |
| Factors That Alter the Relationship |
4:02 | |
| |
| Pathologic Inflammation |
7:05 | |
| |
| Commensal Species |
9:47 | |
| |
| Pathobionts |
10:28 | |
| |
Functional Comparison of the Gut Microbiome with Other Sequenced Microbiomes |
10:38 | |
| |
Genes and Microbiome |
11:34 | |
| |
| Vitamin K Example |
12:00 | |
| |
| Escherichia Coli |
13:07 | |
| |
| Genomes of the Bacteria and Viruses of the Human Gut Encode 3.3 Million Genes |
14:02 | |
| |
Link to Microbiome and Health |
14:57 | |
| |
Antibiotic Resistance |
15:42 | |
| |
| Natural Selection, Survival of the Fittest, Adaptation |
16:39 | |
| |
Theory of Evolution |
17:07 | |
| |
| Origin of Species |
17:13 | |
| |
| Darwin Came Up with Theory |
17:50 | |
| |
Link to Theory of Evolution |
18:01 | |
| |
Natural Selection |
19:03 | |
| |
| Natural Selection |
19:09 | |
| |
| Adaptive Trait |
19:21 | |
| |
Antibiotic Resistant Bacteria |
19:49 | |
| |
| Two Week Course of Antibiotics |
20:10 | |
| |
| Antibiotic Resistant Strains Found in Hospitals and Schools |
21:21 | |
| |
Evolution of Resistant Bacteria |
22:01 | |
| |
Evolution of Resistance |
24:06 | |
| |
| Natural Selection |
24:08 | |
| |
| Some Bacteria Transfers the Resistant Genes to Other Bacteria Who Don't Have It |
24:24 | |
| |
| It Reproduces and Soon Populates an Antibiotic Resistant Infection |
25:06 | |
| |
Antibiotic Resistant Bacteria |
25:30 | |
| |
| Acquired Resistance |
25:31 | |
| |
| Resistance Develops by Mutation of Resident or by Acquisition of New Genes |
26:55 | |
| |
| Flourish in Areas of High Antimicrobial Use |
27:10 | |
| |
Spread of Antibiotic Resistance |
27:19 | |
| |
Selection of Resistant Bacteria by Overuse and Misuse of Antibiotics |
29:02 | |
| |
Multiple Antibiotics |
29:46 | |
| |
Antibiotics Used Unnecessarily |
30:35 | |
| |
| Bacterial and Viral Pneumonia |
31:13 | |
| |
| Indiscriminant Use of Antibiotic |
31:52 | |
| |
| Unnecessary Antibiotics Can Promote Resistant Bacteria |
32:25 | |
| |
| Future Antibiotics May Lose Effectiveness |
32:33 | |
| |
Ease of Obtaining Antibiotics |
33:11 | |
| |
| Over the Counter |
33:13 | |
| |
| Encourages Indiscriminant and Inappropriate Use of Antibiotics |
33:25 | |
| |
Use in Animal Feed |
34:26 | |
| |
| Prevent Infections and Promote Growth |
34:30 | |
| |
| Animals Can Develop Resistance Also |
35:03 | |
| |
Tutorial on Antibiotic Resistance |
36:05 | |
| |
Example 1 |
36:32 | |
| |
Example 2 |
39:30 | |
Section 2: Cell Biology |
|
Biology of the Prototype Cell |
10:02 |
| |
Intro |
0:00 | |
| |
Cellular Organization |
0:14 | |
| |
| Prokaryotes |
0:27 | |
| |
| Eukaryotes |
0:48 | |
| |
Three Domains of Life |
0:51 | |
| |
| Eubacteria |
1:02 | |
| |
| Archaebacteria |
1:09 | |
| |
| Eukaryotes |
1:15 | |
| |
Evolution of Bacteria |
1:21 | |
| |
Common Qualities |
2:02 | |
| |
| Nucleus |
2:12 | |
| |
| Plasma Membrane |
2:47 | |
| |
| Cytoplasm |
3:09 | |
| |
Multicellularity |
3:17 | |
| |
| Multicellularity Evolved |
3:28 | |
| |
| Cells Gave Rise to Earth's First Lineage of Multicellular Organisms |
3:57 | |
| |
| Fossils of Bangiomorpha Pubescens are 1.2 Billion Years Old |
4:18 | |
| |
| Cells Differentiated for Attaching to a Substrate |
4:37 | |
| |
| Longitudinal Division Divides Disc-Shaped Cells Into Radially Arranged Wedge-Shaped Cells |
4:54 | |
| |
According to Energy |
5:08 | |
| |
| Phototrophs |
5:36 | |
| |
| Chemotrophs |
6:02 | |
| |
Introducing Prokaryotic Cells |
6:46 | |
| |
| Bacteria and Archaea |
6:51 | |
| |
| Smallest Form of Life |
6:58 | |
| |
| Similar in Appearance and Size |
7:06 | |
| |
| Aerobic |
7:13 | |
| |
| Anaerobic |
7:19 | |
| |
| Facultative |
7:26 | |
| |
Example 1 |
7:37 | |
| |
Example 2 |
9:02 | |
|
Structures in Common & Structures That Are Unique |
8:40 |
| |
Intro |
0:00 | |
| |
Structures |
0:22 | |
| |
| Way to Remember Cell Structures |
0:23 | |
| |
Membrane Similarities |
0:34 | |
| |
| Both Prokaryotes and Eukaryotes Have Plasma Membrane |
0:42 | |
| |
Replication Molecules |
1:17 | |
| |
| Prokaryotes and Eukaryotes Have DNA and RNA |
1:18 | |
| |
| One Way Prokaryotes and Eukaryotes are Different |
1:41 | |
| |
Genome Differences |
1:49 | |
| |
| Eukaryotes |
1:52 | |
| |
| Prokaryotes |
2:12 | |
| |
Cell Division Differences |
2:43 | |
| |
| Prokaryotes |
2:49 | |
| |
| Eukaryotes |
2:55 | |
| |
Organelle Differences |
3:07 | |
| |
| Eukaryotes |
3:10 | |
| |
| Prokaryotes |
3:31 | |
| |
Energy Metabolism Differences |
3:42 | |
| |
| Eukaryotes |
3:48 | |
| |
| Prokaryotes |
4:21 | |
| |
Cytoskeleton Differences |
4:41 | |
| |
| Eukaryotes |
4:50 | |
| |
| Prokaryotes |
5:27 | |
| |
Example 1 |
5:46 | |
| |
Example 2 |
7:13 | |
|
DNA & RNA |
11:46 |
| |
Intro |
0:00 | |
| |
Which Came First |
0:31 | |
| |
| RNA Came First |
0:38 | |
| |
| Short RNA Molecules |
0:54 | |
| |
| Stored Information |
1:05 | |
| |
Early RNA |
1:21 | |
| |
| Synthesized Proteins and Carried Info |
1:24 | |
| |
| Information Carrying Role of RNA |
1:36 | |
| |
| Evolution of Double-Stranded DNA Enabled the Storage of More Complex Info |
2:01 | |
| |
| DNA Became a Better Mechanism for Information Storage of Complex Traits |
2:13 | |
| |
Replicating Molecules |
2:35 | |
| |
| Replicating Molecules Evolved and Began to Undergo Natural Selection |
2:51 | |
| |
| Replication |
3:05 | |
| |
| Protein Synthesis |
3:13 | |
| |
RNA Evolves Into DNA |
3:24 | |
| |
| DNA Contains Instruction |
3:32 | |
| |
| RNA Transcribes DNA |
3:54 | |
| |
| Proteins Are Made from the Instructions |
3:59 | |
| |
DNA Structure |
4:15 | |
| |
Chromosomal DNA |
5:02 | |
| |
DNA Coiling |
5:26 | |
| |
DNA - Nucleic Functions |
5:51 | |
| |
| Transcription |
6:04 | |
| |
| Replication |
6:29 | |
| |
Function of DNA |
7:10 | |
| |
DNA Replication |
7:36 | |
| |
| Complete Unzipping of DNA |
7:38 | |
| |
| Assembly of Complementary Nucleotides |
7:47 | |
| |
| Only Occurs in Cell Division |
8:09 | |
| |
DNA Replication Diagram |
8:18 | |
| |
DNA Transcription and Translation |
8:41 | |
| |
Example 1 |
9:46 | |
| |
Example 2 |
10:27 | |
| |
Example 3 |
10:45 | |
|
Motility |
11:24 |
| |
Intro |
0:00 | |
| |
Motility is an Important Property |
0:26 | |
| |
| Flagella |
0:37 | |
| |
| Pili |
0:55 | |
| |
Prokaryotic Cell |
1:08 | |
| |
Pili |
1:38 | |
| |
| Fimbriae |
1:45 | |
| |
| Pili Connect a Bacterium to Others of the Same Species |
1:57 | |
| |
| Transferred Plasmids Can Bring a New Function to the Cell |
2:37 | |
| |
Fimbriae |
3:07 | |
| |
| Distributed Over the Entire Surface of the Cell |
3:08 | |
| |
| Have a Tendency to Adhere to Surfaces and to One Another |
3:17 | |
| |
| Example: Neisseria Gonorrhea |
3:40 | |
| |
An Electron Micrograph of E Coli |
3:53 | |
| |
Bacterial Conjugation with Pilus |
4:12 | |
| |
Prokaryotic Flagella |
5:14 | |
| |
| Eukaryotes |
5:34 | |
| |
| Prokaryotes |
5:43 | |
| |
| Underneath Inner Plasma Membrane in Gram Positive and Gram Negative Bacteria |
6:05 | |
| |
Different Types of Flagella |
6:13 | |
| |
| Flagella Organization |
6:14 | |
| |
| Bacteria Alters Speed and Direction of Rotation |
7:11 | |
| |
| Examples |
8:07 | |
| |
Example 1 |
8:41 | |
| |
Example 2 |
10:05 | |
|
Plasma Membrane |
16:11 |
| |
Intro |
0:00 | |
| |
Plasma Membrane |
0:22 | |
| |
| Functions of Plasma Membrane |
0:28 | |
| |
| Physical Isolation |
0:31 | |
| |
| Regulation of Exchange with the Environment |
1:05 | |
| |
| Communication Between the Cell and Its Environment |
1:46 | |
| |
| Structural Support |
2:28 | |
| |
Plasma Membrane Composition |
2:46 | |
| |
| Lipids |
2:59 | |
| |
| Proteins |
3:17 | |
| |
| Carbohydrates |
3:43 | |
| |
Lipid Bi-Layer of Plasma Membrane |
4:19 | |
| |
| Micelle |
4:28 | |
| |
| Bilayer |
5:11 | |
| |
| Liposome |
5:40 | |
| |
Cellular Evolution |
5:59 | |
| |
| Evoloution of Membranes Advantages |
6:49 | |
| |
| Encased Cells Out-Competed Naked Cells |
7:37 | |
| |
Plasma Membrane Structure |
7:57 | |
| |
Plasma Membrane Differences |
10:59 | |
| |
| Eukaryotic Cells Have Carbohydrates |
11:11 | |
| |
| Eukaryotic Plasma Membranes Contain Sterols |
12:08 | |
| |
| Prokaryotic Plasma Membranes Consist Mostly of Phospholipids and Proteins |
12:26 | |
| |
Example 1 |
12:41 | |
| |
Example 2 |
13:30 | |
| |
Example 3 |
15:02 | |
|
Antibody & Antigen Recognition |
15:50 |
| |
Intro |
0:00 | |
| |
Finding and Cell Signaling |
0:22 | |
| |
Ligand Binding |
1:00 | |
| |
| Ligand Binds |
1:01 | |
| |
| Binding Site is Complementary to the Ligand |
1:30 | |
| |
| Interaction Between Ligand and Binding Site is Specific |
2:39 | |
| |
| Induced Fit |
3:24 | |
| |
Ligand Binding Illustration 1 |
3:44 | |
| |
Ligand Binding Illustration 2 |
4:21 | |
| |
Antibody Structure |
4:44 | |
| |
Antigen-Antibody Specificity |
5:40 | |
| |
Antigen-Antibody Reaction |
6:27 | |
| |
Example 1 |
10:10 | |
| |
Example 2 |
11:54 | |
| |
Example 3 |
13:29 | |
|
Microbial Metabolism |
21:44 |
| |
Intro |
0:00 | |
| |
Organisms and Carbon |
0:20 | |
| |
| Autotrophs |
0:40 | |
| |
| Heterotrophs |
1:12 | |
| |
Organisms and Energy |
2:07 | |
| |
Metabolism |
3:19 | |
| |
| Metabolism |
3:26 | |
| |
| Catabolism |
3:53 | |
| |
| Anabolism |
4:15 | |
| |
Cellular Respiration |
4:56 | |
| |
| Aerobic Respiration |
5:47 | |
| |
| Anaerobic Respiration |
6:13 | |
| |
Glucose |
6:41 | |
| |
| Most Important Carbohydrate |
6:42 | |
| |
| Three Major Outcomes |
7:14 | |
| |
| Stored |
7:21 | |
| |
| Oxidized via Glycolysis |
7:22 | |
| |
| Oxidized via the Pentose Phosphate |
7:50 | |
| |
Outcomes of Glucose I |
8:37 | |
| |
Outcomes of Glucose II |
10:21 | |
| |
Overview of Aerobic Metabolism |
11:50 | |
| |
| Glycolysis |
12:01 | |
| |
| Citric Acid Cycle |
12:05 | |
| |
| Oxidative Phosphorylation |
12:13 | |
| |
| Formula |
12:17 | |
| |
Aerobic Metabolism |
12:28 | |
| |
Respiration and Fermentation |
13:52 | |
| |
Carbohydrate Catabolism |
15:00 | |
| |
Overview of Anaerobic Metabolism |
15:59 | |
| |
| Energy in Glucose is Released Without the Presence of Oxygen |
16:00 | |
| |
| Lactic Acid |
16:08 | |
| |
ATP Production Requirements |
17:13 | |
| |
| Energy Sources |
17:22 | |
| |
| Electron Carriers |
17:41 | |
| |
| Final Electron Acceptors |
17:49 | |
| |
Example 1 |
18:09 | |
| |
Example 2 |
18:41 | |
| |
Example 3 |
20:13 | |
|
Microbial Genetics |
39:49 |
| |
Intro |
0:00 | |
| |
What is a Gene? |
0:39 | |
| |
| A Portion of the Chromosome That Determines or Affects a Single Character or Phenotype |
0:51 | |
| |
| Biochemical Definition of a Gene |
0:57 | |
| |
| Original Definition: One Gene-One Polypeptide |
1:20 | |
| |
What is a Gene? |
1:48 | |
| |
| Regulatory Sequence |
1:50 | |
| |
Genetic Code |
2:44 | |
| |
Transcription and Replication |
3:56 | |
| |
Replication of Bacterial DNA |
5:05 | |
| |
| Copy Both Sides of DNA Strand |
5:20 | |
| |
DNA Transcription |
5:53 | |
| |
| DNA is Transcribed to Make RNA |
6:18 | |
| |
| RNA Polymerase Binds to the Promoter Sequence |
6:24 | |
| |
| Direction |
6:29 | |
| |
| Transcription Stops When It Reaches the Terminator Sequence |
6:33 | |
| |
Bacterial Transcription |
6:39 | |
| |
| Transcription |
6:46 | |
| |
| No Nucleus |
6:52 | |
| |
Translation |
7:51 | |
| |
| mRNA is Translated In Codons |
8:11 | |
| |
| Translation of mRNA Begins at the Start Codon |
8:18 | |
| |
| Translation Ends at Nonsense Codon |
8:22 | |
| |
Gene Regulation |
8:34 | |
| |
| Constitutive Genes Are Expressed at a Fixed Rate |
8:43 | |
| |
| Other Genes Are Expressed Only as Needed |
8:58 | |
| |
Regulation of Transcription |
9:11 | |
| |
Repression |
10:16 | |
| |
Induction |
11:04 | |
| |
Germline Mutation |
12:09 | |
| |
| Evolutionary Biology |
12:32 | |
| |
| Molecular Biology |
13:48 | |
| |
Mutations |
14:34 | |
| |
| Random and Rare |
14:36 | |
| |
| Can Be Beneficial or Neutral |
14:46 | |
| |
| Not All Mutations Matter |
14:58 | |
| |
| Somatic Mutations |
15:20 | |
| |
| Germline Mutations |
16:30 | |
| |
Causes of Mutations |
16:44 | |
| |
| DNA Fails to Copy Accurately |
16:48 | |
| |
| External Influences Can Create Mutations |
17:21 | |
| |
Types of Mutations |
18:14 | |
| |
| Substitution |
18:18 | |
| |
| Examples of Substitutions |
18:29 | |
| |
| Silent Mutations |
19:56 | |
| |
| Insertion |
20:39 | |
| |
| Deletion |
20:51 | |
| |
| Frame Shift |
21:12 | |
| |
Bacterial Gene Recombination |
22:16 | |
| |
| Vertical Gene Transfer |
22:57 | |
| |
| Horizontal Gene Transfer |
23:16 | |
| |
Genetic Recombination |
23:46 | |
| |
| Exchange of Genes Between Two DNA Molecules |
23:47 | |
| |
| Crossing Over Occurs When Two Chromosomes Break and Rejoin |
23:52 | |
| |
| Recipient Chromosome Contains New DNA |
23:57 | |
| |
Bacterial Recombination |
24:51 | |
| |
Bacterial Transformation |
25:53 | |
| |
Conjugation in E. Coli |
28:36 | |
| |
Transduction by a Bacteriophage |
30:04 | |
| |
Plasmids |
31:53 | |
| |
| What are Plasmids? |
32:00 | |
| |
| F-Factor |
32:14 | |
| |
| Other Plasmids Encode for Proteins That Enhance the Pathogenicity of a Bacterium |
32:39 | |
| |
| Dissimilation Plasmids |
33:24 | |
| |
| R Factors |
33:44 | |
| |
R-Factor, A Type of Plasmid |
33:53 | |
| |
Transposons |
35:04 | |
| |
| Move From One Region of DNA to Another |
35:29 | |
| |
| Contain Insertion Sequences for Cutting and Resealing DNA (Tansposase) |
35:34 | |
| |
Example 1 |
36:14 | |
| |
Example 2 |
37:34 | |
| |
Example 3 |
38:15 | |
Section 3: Virus Biology |
|
Viral Structure, Genome, & Replication |
16:50 |
| |
Intro |
0:00 | |
| |
Medical Virology |
0:11 | |
| |
| Viral Structure |
1:37 | |
| |
| Viral Genome |
1:55 | |
| |
What is a Virus? |
2:09 | |
| |
| Smaller |
2:15 | |
| |
| DNA or RNA with no Nucleus |
2:34 | |
| |
Classification of Viruses |
3:03 | |
| |
| Type and Confirmation of Genomic Nucleic Acid |
3:07 | |
| |
| Viral Morphology |
3:19 | |
| |
Viral Structure |
3:54 | |
| |
| Virion |
3:58 | |
| |
| Envelope |
4:29 | |
| |
| Capsid |
5:39 | |
| |
| Nucleocapsid |
5:55 | |
| |
Viral Genome - Composition |
6:27 | |
| |
| Viral Genome |
6:31 | |
| |
| DNA vs. RNA Structure |
6:42 | |
| |
| RNA |
7:49 | |
| |
| Pathogenicity & Virulence |
7:42 | |
| |
| DNA |
8:06 | |
| |
Viral Genome - Shape |
8:36 | |
| |
| Segmented |
8:40 | |
| |
| Non-segmented |
9:22 | |
| |
Changes in the Viral Genome |
9:36 | |
| |
| Genetic Recombination |
9:56 | |
| |
| Reassortment |
10:26 | |
| |
Changes in the Viral Genome |
11:16 | |
| |
| Quasi-species |
11:24 | |
| |
| Ebola Virus |
11:58 | |
| |
Example 1 |
12:33 | |
| |
Example 2 |
13:42 | |
| |
Example 3 |
15:13 | |
|
Viral Entry Into a Cell & Transmission |
12:31 |
| |
Intro |
0:00 | |
| |
Medical Virology |
0:27 | |
| |
| Viral Entry Into a Cell |
0:30 | |
| |
| Viral Transmission |
0:39 | |
| |
Viral Entry into Cells |
0:53 | |
| |
| Attachment |
0:58 | |
| |
| Membrane Fusion |
1:29 | |
| |
| Pre Formation |
1:56 | |
| |
| Penetration |
2:12 | |
| |
Transmission of Viruses |
2:34 | |
| |
| Aerosol |
2:51 | |
| |
| Contaminated Food |
3:19 | |
| |
| Arthropods |
4:01 | |
| |
| Sexual Contact |
5:06 | |
| |
| Organ and Tissue Transplant |
5:22 | |
| |
Site of Virus Entry |
6:17 | |
| |
| Respiratory Tract |
6:37 | |
| |
| GI Tract |
7:08 | |
| |
| Urethra, Vagina, Anus |
7:34 | |
| |
| Skin |
7:42 | |
| |
| Conjunctiva |
7:45 | |
| |
| Type of Cell Best Suited for Virus |
7:57 | |
| |
Example 1 |
9:23 | |
| |
Example 2 |
10:13 | |
|
Medically Important Viruses |
24:41 |
| |
Intro |
0:00 | |
| |
Medical Virology |
0:41 | |
| |
| Viruses We Will Study |
1:00 | |
| |
| How the Viruses Differs |
1:10 | |
| |
Medically-Important Viruses |
1:23 | |
| |
Selected Viruses of Medical Importance |
2:55 | |
| |
| Herpesviridae, Simplevirus |
2:59 | |
| |
| Herpes Virus |
4:09 | |
| |
| Papillomaviridae, Alphapapillomavirus |
4:47 | |
| |
| Papilloma Virus |
5:27 | |
| |
| Reoviridae, Rotavirus |
6:57 | |
| |
| Rotavirus |
7:58 | |
| |
| Paramyxovirinae, Morbilivirus |
9:04 | |
| |
| Measles Virus |
10:19 | |
| |
| Orthomyxoviridae (Influenza Virus) |
10:58 | |
| |
| Influenza Virus - Antigenic Drift |
12:52 | |
| |
| Influenza Virus - Antigenic Shift |
15:19 | |
| |
Medically-Important Viruses |
18:39 | |
| |
| Avian Influenza |
18:41 | |
| |
Example 1 |
20:19 | |
| |
Example 2 |
21:50 | |
| |
Example 3 |
23:01 | |
Section 4: Classification of Microbes |
|
Overall Classification of Microbes |
15:51 |
| |
Intro |
0:00 | |
| |
What is Taxonomy? |
0:18 | |
| |
| Science of Classifying Organisms |
0:21 | |
| |
| Universal Names Used by All Countries |
1:11 | |
| |
| Reference for Identifying Organisms |
1:19 | |
| |
| Binomial Nomenclature |
1:28 | |
| |
Systematics or Phylogeny |
2:11 | |
| |
| Phylogeny |
2:12 | |
| |
| Like Reading a Family Tree |
2:28 | |
| |
| Root of the Tree |
2:33 | |
| |
| Moving Forward in Time |
2:49 | |
| |
| Clade |
3:01 | |
| |
| Ancestors and Lineage |
3:39 | |
| |
Taxonomic Hierarchy |
4:17 | |
| |
| Genus and Species |
4:28 | |
| |
| Classification Changes |
4:38 | |
| |
History of Microbial Taxonomy |
4:51 | |
| |
| Discovery of Microscope |
5:09 | |
| |
| Kingdoms Plantae and Animalia |
5:33 | |
| |
| Smallpox Vaccine |
5:42 | |
| |
| Bacteria and Fungi |
6:11 | |
| |
| Kingdom Portista |
6:24 | |
| |
| Prokaryotes Introduced as a New Kingdom |
6:57 | |
| |
| Definition of Prokaryote |
7:17 | |
| |
| Kingdom Fungi |
7:33 | |
| |
| Kingdom Prokaryote |
7:40 | |
| |
| Two Types of Prokaryotic Cells |
7:48 | |
| |
Using Molecular Techniques to Classify |
7:58 | |
| |
| Classify Microbes |
8:24 | |
| |
| Three Domain System of Classification |
9:21 | |
| |
Classification Criteria |
9:29 | |
| |
| Physiology |
9:58 | |
| |
| Ecology |
10:06 | |
| |
| Behavior |
10:27 | |
| |
| Morphology |
10:54 | |
| |
| Molecular Evidence (RNA) |
11:11 | |
| |
Three Domains of Life |
11:39 | |
| |
| Eukaryotes |
11:46 | |
| |
| Prokaryotes |
11:48 | |
| |
| Archaea |
11:54 | |
| |
Example 1 |
12:13 | |
| |
Example 2 |
13:15 | |
|
Prokaryotes: Bacteria & Archaea |
12:14 |
| |
Intro |
0:00 | |
| |
Classification of Prokaryotes |
0:45 | |
| |
| Lack of Nucleus |
0:51 | |
| |
| Culture |
1:05 | |
| |
| Clone |
1:19 | |
| |
| Strain |
1:37 | |
| |
Phylogenetic Relationship |
2:02 | |
| |
Archaea |
3:53 | |
| |
| Two Distinct Groups: Archaea and Bacteria |
4:05 | |
| |
| Archaea Lived in High Temperatures |
4:29 | |
| |
| Habitats |
4:51 | |
| |
| Only Habitants to Live in Extreme Habitats |
5:24 | |
| |
| New Research Shoes Archaeans are Abundant in the Open Sea |
5:40 | |
| |
Archaea Morphology |
5:59 | |
| |
| Basic Archaeal Structure: Cytoplasm, Cell Membrane, and Cell Wall |
6:08 | |
| |
| Archaeal Cell Membranes |
6:13 | |
| |
| Plasmid |
7:11 | |
| |
| Archaeal Ribosomes |
7:29 | |
| |
Example 1 |
8:20 | |
| |
Example 2 |
11:01 | |
Section 5: The Immune System |
|
The Immune System |
20:18 |
| |
Intro |
0:00 | |
| |
Immune System Introduction |
0:28 | |
| |
| Body Defends Itself from Anything Foreign |
0:49 | |
| |
| What Immunity Constitutes |
1:13 | |
| |
| Immune Responses Can be Classified as Nonspecific or Specific |
1:27 | |
| |
| Nonspecific Immune Response |
1:54 | |
| |
| Specific Immune Response |
2:22 | |
| |
| Physiological Barriers |
2:49 | |
| |
The Immune System |
3:18 | |
| |
| Innate Immune Response |
3:20 | |
| |
| Adaptive Immune Response |
3:42 | |
| |
Immunity |
4:47 | |
| |
| Immunology |
5:32 | |
| |
| Immunity |
5:39 | |
| |
| Immune System |
6:21 | |
| |
Barriers to Infection - Mechanical |
6:41 | |
| |
| Physical Barriers |
6:54 | |
| |
| Epithelial Surfaces |
8:31 | |
| |
| Mucosal Surfaces |
9:54 | |
| |
| Muco-ciliary Escalator |
10:40 | |
| |
Barriers to Infection - Chemical |
11:25 | |
| |
| Enzymes |
11:33 | |
| |
| pH |
12:29 | |
| |
| Lung |
13:48 | |
| |
Physiological Barriers |
14:56 | |
| |
The Immune System |
16:52 | |
| |
Example 1 |
17:15 | |
|
The Complement System |
16:53 |
| |
Intro |
0:00 | |
| |
What is Complement? |
0:37 | |
| |
| Proteins |
0:40 | |
| |
| Synthesized by Different Cell Types |
1:01 | |
| |
Complement System |
1:14 | |
| |
| Destroy Pathogens Directly |
1:51 | |
| |
| Activate Other Components of the Immune Response |
2:02 | |
| |
| Collaborate with Other Components of the Immune Response |
2:12 | |
| |
| Classical Pathway |
2:28 | |
| |
| Lection Pathway |
3:29 | |
| |
| Alternative Pathway |
3:52 | |
| |
Integral Protein Types That Function in Cell-Cell Interaction |
4:08 | |
| |
Function of the Complement System |
4:49 | |
| |
| Complement is Activated Upon Infection |
4:50 | |
| |
| Complement Functions Like Enzymes |
6:16 | |
| |
Enzyme Activation |
6:37 | |
| |
Function of the Complement System |
7:43 | |
| |
| Complements the Ability of Antibodies and Phagocytic Cells to Identify and Remove Foreign Pathogens |
7:49 | |
| |
| Amplification |
8:50 | |
| |
Activation of the Complement System |
9:17 | |
| |
| Cytolysis |
9:27 | |
| |
| Chemotaxis |
9:39 | |
| |
| Opsonization |
10:41 | |
| |
| Anaphylatoxins |
11:16 | |
| |
Complement and Membrane Attack Complex |
12:10 | |
| |
The Membrane Attached Complex |
12:49 | |
| |
Pathways of Complement Activation |
13:07 | |
| |
| Classical |
13:43 | |
| |
| Lectin |
13:54 | |
| |
| Alternative |
14:07 | |
| |
Example 1 |
14:33 | |
| |
Example 2 |
15:23 | |
| |
Example 3 |
16:11 | |
|
Adaptive Immunity |
31:10 |
| |
Intro |
0:00 | |
| |
What is Adaptive Immunity? |
0:27 | |
| |
| Primary Immune Response |
0:41 | |
| |
| Initiated by a Dendritic Cell That Ingested a Pathogen |
1:24 | |
| |
| Naïve B Cells are Stimulated to Proliferate and Differentiate in Specific Response to the Pathogen |
1:49 | |
| |
| Process of Adaptive Immunity |
2:28 | |
| |
Humoral Immunity |
3:03 | |
| |
Development of Acquired Immune Cells |
3:41 | |
| |
The B Cell |
4:50 | |
| |
| Produced in the Bone Marrow |
4:52 | |
| |
| Outer Surface Contains a Specialized B Cell Receptor |
5:01 | |
| |
| Initial Activation |
5:55 | |
| |
| Secondary Activation |
6:15 | |
| |
Hallmarks of Humoral Immunity |
6:23 | |
| |
| B Lymphocyte is the Central Cell |
6:51 | |
| |
| Antibody-mediated |
6:58 | |
| |
| Highly Complex |
7:03 | |
| |
Step 1: Antigen Recognition |
7:18 | |
| |
| B Cells Recognize Extracellular Antigenics |
7:22 | |
| |
| Antigens on Pathogen Surfaces |
7:54 | |
| |
Step 2: Clonal Expansion |
10:43 | |
| |
| B Cell Divides |
10:48 | |
| |
| Clone |
11:46 | |
| |
| Maturation of B Cells |
12:33 | |
| |
Step 3: Differentiation |
13:46 | |
| |
| B Cells Differentiate Into Plasma Cells |
13:49 | |
| |
| Plasma Cell Produces and Secrets Antibodies Specific to the Origin Antigen |
14:00 | |
| |
| Produce and Secrete Abs Specific to the Original Antigen |
15:38 | |
| |
| Antigen Presenting Cells Show Protein Antigens to Helper T Cells |
15:55 | |
| |
Step 4: Antigen Elimination |
16:30 | |
| |
| Newly-Manufactured Antibodies Attach to the Antigen |
16:36 | |
| |
| Termination of the Humoral Immune Response |
17:30 | |
| |
Step 5: Immune Memory |
18:32 | |
| |
| Memory B Cells Reside in Bone Marrow |
18:53 | |
| |
| High-Affinity Immunoglobulins |
19:15 | |
| |
| Survive for Years |
20:15 | |
| |
| Respond Rapidly When the Antigen is Seen Again |
20:39 | |
| |
Antibodies |
22:34 | |
| |
| Classes - IgM |
22:41 | |
| |
Example 1 |
24:51 | |
| |
Example 2 |
26:54 | |
| |
Example 3 |
28:03 | |
|
Antibody & Antigen Interactions |
41:22 |
| |
Intro |
0:00 | |
| |
Antibody-Antigen |
0:22 | |
| |
Where Do Antigens-Antibodies Belong? |
0:57 | |
| |
What is an Antibody? |
1:12 | |
| |
| Immunoglobulin |
1:17 | |
| |
| Definition of Antibody |
1:32 | |
| |
| Each Antigen is Specific to an Antigen |
1:58 | |
| |
| Antigen Binds to an Antigen |
2:44 | |
| |
| Produced by Plasma Cells |
3:18 | |
| |
Antibody Structure |
3:55 | |
| |
| Paratope |
4:17 | |
| |
| Hinge Region |
4:53 | |
| |
| Fragment Crystallizable |
5:44 | |
| |
Antibody Function |
6:21 | |
| |
| Recognizes and Captures Foreign Proteins and Molecules |
6:41 | |
| |
| Activates Complement |
6:52 | |
| |
| Binds to Immune Cells to Activate Their Specific Functions |
7:55 | |
| |
The Antibody Isotypes |
9:25 | |
| |
| IgM |
9:37 | |
| |
| IgG |
12:36 | |
| |
| IgD |
14:01 | |
| |
| IgA |
14:27 | |
| |
| IgE |
14:45 | |
| |
What is an Antigen? |
15:18 | |
| |
| An Antigen is to Provoke an Immune Response |
15:53 | |
| |
| Exogenous |
16:43 | |
| |
| Endogenous |
17:16 | |
| |
| Autogenous |
18:10 | |
| |
Antigen-Antibody Reaction |
19:08 | |
| |
| Affinity |
19:33 | |
| |
| Avidity |
19:57 | |
| |
| Specificity |
21:02 | |
| |
| Cross Reactivity |
21:31 | |
| |
| Foreignness |
22:17 | |
| |
| Size |
24:32 | |
| |
What Determines Antigenicity? |
25:04 | |
| |
| Antigenicity Definition |
25:13 | |
| |
| Conformation |
25:29 | |
| |
| Composition |
26:02 | |
| |
| Bacterial Components |
26:27 | |
| |
Antigenic Determinants: Innate Immunity |
26:53 | |
| |
Example 1 |
30:41 | |
| |
Example 2 |
33:15 | |
| |
Example 3 |
36:37 | |
|
Tumor Immunology |
33:16 |
| |
Intro |
0:00 | |
| |
Antibodies Surrounding Tumor |
0:40 | |
| |
Introduction to Tumor Immunology |
1:22 | |
| |
| Human Papilloma |
1:41 | |
| |
| Hepatitis B |
2:26 | |
| |
| Helicobacter Pylori |
2:47 | |
| |
| Immunology |
4:05 | |
| |
Overview of Tumor Immunology |
4:17 | |
| |
| Immune Surveillance Theory |
4:18 | |
| |
| Malignant Transformation |
4:34 | |
| |
| Immune Reactivity to Tumors |
4:37 | |
| |
| Tumor Antigens |
4:43 | |
| |
| Tumor Immunotherapies |
4:49 | |
| |
| Inflammation and Cancer |
4:53 | |
| |
Immune Surveillance Theory and Escape |
4:59 | |
| |
| Amount of Antigen Expressed is Too Low |
5:51 | |
| |
| Tumor Sheds Antigens That Block Antibodies and T-Cells from binding to the Tumor |
6:01 | |
| |
| Tumor Does Not Express Immunogenic Antigens |
6:15 | |
| |
| Tumor Does Not Express MHC Antigens |
6:32 | |
| |
| Tumor May Secrete Immunosuppressive |
6:51 | |
| |
| Hallmark of a Cancer Cell is Proliferation That is Dysregulated |
7:12 | |
| |
Malignant Transformation |
7:39 | |
| |
| One Way to Cause Growth Regulations |
8:24 | |
| |
| Mutations Can Alter the Cellular Machinery Leading to Up Regulation of Oncogenes |
8:45 | |
| |
| Mutations Can Alter the Cellular Machinery Leading to Down Regulation of Tumor Suppressor Genes |
9:15 | |
| |
Tumor Growth Over Time |
9:42 | |
| |
Malignant Transformation |
10:46 | |
| |
| Benign |
11:20 | |
| |
| Malignant |
11:37 | |
| |
Progression of Benign to Malignant |
12:35 | |
| |
Micro-Induced Carcinogenesis |
13:40 | |
| |
| Initiation Promotion Progression Model |
14:28 | |
| |
Examples of Malignant Transformation |
14:53 | |
| |
Tumor Antigens |
15:46 | |
| |
| Tumor Must Express Antigens That the Immune System Recognizes as Foreign |
16:16 | |
| |
| Immune Reactivity to Tumors |
16:40 | |
| |
| Tumor Antigens |
17:07 | |
| |
| Tumor Immunotherapies |
17:15 | |
| |
| Tumorigenesis Secretes Chemical Signals That Change Gene Expression |
17:25 | |
| |
| Gene Expression Leads To The Following |
17:30 | |
| |
Tumors in an Immunosuppressed Host |
18:48 | |
| |
| HIV and AIDS |
19:13 | |
| |
| Transplant Patients |
19:55 | |
| |
| Epstein-Barr Virus |
20:19 | |
| |
| Malaria |
20:27 | |
| |
Tumor Immunotherapies |
20:45 | |
| |
| Active Therapy |
21:01 | |
| |
| Passive Therapy |
22:02 | |
| |
Inflammation and Cancer |
24:05 | |
| |
| Chronic Inflammation |
24:18 | |
| |
| Inflammation as a Response to Cancer |
25:23 | |
| |
| Neoplastic Cells Induce an Inflammatory Immune System |
25:34 | |
| |
Bacteria, Inflammation, and Cancer |
25:59 | |
| |
Example 1 |
27:46 | |
| |
Example 2 |
29:21 | |
| |
Example 3 |
30:25 | |
| |
Example 4 |
31:28 | |
|
Cell Mediated Immunity |
57:13 |
| |
Intro |
0:00 | |
| |
Adaptive Immunity |
0:43 | |
| |
Cell-Mediated Immunity |
1:47 | |
| |
| Lymphocyte T Cell |
1:56 | |
| |
| Antigen-Presenting Cells |
2:15 | |
| |
| Subset of T Cells |
2:22 | |
| |
| Immune Tolerance |
2:31 | |
| |
Hallmarks of Cell-Mediated Immunity |
3:02 | |
| |
| Primary Actor is the T Lymphocyte |
3:06 | |
| |
| Directed at Pathogens That Survive in Phagocytes |
3:12 | |
| |
| Based on Activation |
3:23 | |
| |
| Induce Apoptosis in Cells Displaying Epitopes of Foreign Antigens |
4:25 | |
| |
| Activates Macrophages and Natural Killer Cells |
6:34 | |
| |
| Stimulates Cells to Secrete Cytokines That Signal Other Cells of the Humoral and Innate Immune Response |
6:47 | |
| |
| Responds to Intracellular Antigens |
7:16 | |
| |
| Requires Direct, Cell-to-Cell Contact |
7:24 | |
| |
The T-Cell |
7:51 | |
| |
| Mature in the Thymus |
7:58 | |
| |
| Presence of the T-Cell Receptor |
8:04 | |
| |
| Important Components |
8:35 | |
| |
| Antigen-Presenting Cell |
9:36 | |
| |
| Type of Leukocyte |
11:17 | |
| |
| Responsible for the Immune Responses That Lead to the Following |
11:25 | |
| |
T-Cell Maturation |
13:34 | |
| |
| Thymocyte |
13:42 | |
| |
| Thymopoiesis |
13:59 | |
| |
| Thymus Conducts a Testing Process of Positive and Negative Selection |
14:15 | |
| |
| Somatic Gene Rearrangement |
15:49 | |
| |
| Infinite Number of Configurations That Create TCRs |
17:00 | |
| |
Cluster of Differentiation (CD) |
17:27 | |
| |
| Function |
18:23 | |
| |
| Immuno-Phenotyping |
19:18 | |
| |
Cluster of Differentiation (CD) |
19:34 | |
| |
| Nomenclature |
19:40 | |
| |
| Example |
20:01 | |
| |
Antigen-Presenting Cells |
20:50 | |
| |
| Antigen Presentation |
21:24 | |
| |
| Antigen-Presenting Cells |
21:32 | |
| |
| Direct Presentation |
21:52 | |
| |
| Cross-Presentation |
22:37 | |
| |
| Cross-Dressing |
23:04 | |
| |
| Professional |
23:24 | |
| |
| Others |
23:55 | |
| |
| Contact Between an APC and TCR Stimulates Important Signaling Events |
25:20 | |
| |
T-Cell Subset: T-Helper Cells |
25:51 | |
| |
| Th1 |
27:05 | |
| |
| Th2 |
28:48 | |
| |
| Th17 |
29:43 | |
| |
T-Cell Subset: Cytotoxic (Killer) T-Cells |
31:26 | |
| |
| CD8+ Cells |
31:28 | |
| |
| Target Cells with Antigen |
31:50 | |
| |
T-Cell Subset: Cytotoxic (Killer) T-Cells |
32:55 | |
| |
| Perforin |
33:30 | |
| |
| Granzyme |
34:07 | |
| |
| Pharmaceuticals are Designed to Alter T-Cell Responses |
35:00 | |
| |
T-Cell Subset: Regulatory T-Cells |
37:01 | |
| |
| Suppress Activation of the Immune System |
37:40 | |
| |
| Functions |
38:36 | |
| |
T-Cell Subset: Regulatory T-Cells |
39:45 | |
| |
| Commensal Bacteria |
39:51 | |
| |
| Graft/ Transplant |
41:02 | |
| |
| Pregnancy |
41:41 | |
| |
| Tumors |
41:47 | |
| |
Cytokines |
42:46 | |
| |
| Types of Cytokines |
42:57 | |
| |
| Chemical Messengers |
43:19 | |
| |
| Functional Classes of Cytokines |
43:38 | |
| |
Chemokines |
47:17 | |
| |
| Chemotaxis |
47:20 | |
| |
| Inflammation |
48:54 | |
| |
| Homeostatic |
49:10 | |
| |
| Antiviral Response |
49:23 | |
| |
| Designation |
49:27 | |
| |
Pulling It All Together |
49:40 | |
| |
Example 1 |
51:40 | |
| |
Example 2 |
52:51 | |
| |
Example 3 |
54:56 | |
Section 6: The Bacteria |
|
Bacterial Cell Wall |
18:38 |
| |
Intro |
0:00 | |
| |
Overview |
0:45 | |
| |
| Gram Negative and Positive Bacteria |
1:17 | |
| |
| Bacteria Without Cell Walls |
1:38 | |
| |
Recall the Prototype Cell |
1:52 | |
| |
| Plasma Membrane |
2:15 | |
| |
| Cytoplasm |
2:21 | |
| |
| Nucleus |
2:26 | |
| |
Cell Wall Principles |
2:41 | |
| |
| Protects Bacteria |
2:50 | |
| |
| Survive in Fluid Environments |
3:08 | |
| |
| Attack by Antibiotics |
4:26 | |
| |
| Source of Identification |
4:40 | |
| |
Peptidoglycan |
4:47 | |
| |
| Murein |
5:10 | |
| |
| Protects the Plasma Membrane |
5:18 | |
| |
| Gram Staining |
5:42 | |
| |
Gram Positive and Gram Negative |
5:55 | |
| |
Gram Positive Bacterial Cell Wall |
8:26 | |
| |
| Thick Structure |
8:45 | |
| |
| Gram Staining |
8:52 | |
| |
| Teichoic Acids in Cell Wall |
9:06 | |
| |
| Gram Positive Streptococci |
9:21 | |
| |
Gram Negative Bacterial Cell Wall |
9:57 | |
| |
| Allows More Complexity |
10:15 | |
| |
| Outer Membrane Provides Barrier to Certain Antibiotics |
11:00 | |
| |
| Outer Membrane Contains Lipid A |
11:34 | |
| |
The Gram Stain |
12:36 | |
| |
| Hans Christian Gram Invented a Stain to Visualize Bacteria |
12:52 | |
| |
| Gram Positive Bacteria |
13:51 | |
| |
| Gram Negative Bacteria |
14:27 | |
| |
Example 1 |
14:55 | |
| |
Example 2 |
15:49 | |
|
Bacterial Morphology & Shape |
15:04 |
| |
Intro |
0:00 | |
| |
Bacteria Morphology and Shape |
0:28 | |
| |
Classification of Bacteria |
0:50 | |
| |
| Based on Several Major Properties |
0:53 | |
| |
| Taxonomy Principles Do Not Quite Fit for Bacteria |
1:21 | |
| |
Variation in Shape and Distribution |
3:00 | |
| |
| Cocci |
3:14 | |
| |
| Bacilli |
4:00 | |
| |
| Budding and Appendaged Bacteria |
4:27 | |
| |
| Others |
4:35 | |
| |
Bacterial Distribution |
4:51 | |
| |
Shapes of Bacteria |
5:45 | |
| |
Bacterial Shapes |
6:40 | |
| |
| Three Basic Shapes |
6:41 | |
| |
| Variation in Shapes |
7:12 | |
| |
| Clusters |
7:31 | |
| |
| Clusters Example |
7:50 | |
| |
Streptococcus Pneumoniae |
8:18 | |
| |
Bacterial Shapes |
8:56 | |
| |
| Streptococci |
9:00 | |
| |
| Staphylococci |
9:12 | |
| |
| Comma Shaped |
10:28 | |
| |
| Vibrios |
10:37 | |
| |
| Spirilla |
11:04 | |
| |
| Spirochetes |
11:25 | |
| |
Example 1 |
11:38 | |
| |
Example 2 |
12:39 | |
| |
Example 3 |
13:24 | |
|
Bacterial Metabolic Behavior |
23:50 |
| |
Intro |
0:00 | |
| |
Energy Metabolism |
0:40 | |
| |
Classification of Bacteria |
1:48 | |
| |
| Metabolic Behavior |
1:51 | |
| |
| Some Organisms are Anaerobic |
1:57 | |
| |
Organisms and Carbon |
2:07 | |
| |
| Autotrophs |
2:10 | |
| |
| Heterotrophs |
2:43 | |
| |
Organisms and Energy |
3:28 | |
| |
Metabolism |
4:13 | |
| |
| Metabolism |
4:14 | |
| |
| Catabolism |
4:50 | |
| |
| Anabolism |
5:04 | |
| |
Cellular Respiration |
5:49 | |
| |
| Aerobic Respiration |
6:55 | |
| |
| Anaerobic Respiration |
7:13 | |
| |
Glucose |
7:41 | |
| |
| Energy-Currency Molecule for Autotrophs and Heterotrophs |
7:42 | |
| |
| Three Major Outcomes |
7:56 | |
| |
Outcomes of Glucose |
8:18 | |
| |
Outcomes of Glucose and Pyruvate |
9:07 | |
| |
Overview of Aerobic Metabolism |
11:19 | |
| |
| Glycolysis |
11:25 | |
| |
| Citric Acid Cycle |
11:28 | |
| |
| Oxidative Phosphorylation |
11:30 | |
| |
Aerobic Metabolism |
11:51 | |
| |
Respiration and Fermentation |
13:18 | |
| |
Carbohydrate Catabolism |
14:35 | |
| |
Overview of Anaerobic Metabolism |
15:37 | |
| |
| Energy in Glucose is Released Without the Presence of Oxygen |
15:48 | |
| |
| Lactic Acid |
15:46 | |
| |
Types of Fermentation |
16:16 | |
| |
| Lactic Acid Fermentation |
16:20 | |
| |
| Alcohol Fermentation |
16:27 | |
| |
Alcohol Fermentation |
16:57 | |
| |
| Any Spoilage of Food by Microorganisms |
17:08 | |
| |
| Any Process that Produces Alcoholic Beverages |
17:14 | |
| |
| Any Large-Scale Microbial Process Occurring With or Without Air |
17:25 | |
| |
| Yeast and Other Microorganisms Ferment Glucose to Ethanol |
17:39 | |
| |
| Two Step Process |
18:07 | |
| |
Lactic Acid Fermentation |
18:34 | |
| |
| Classic Anaerobic Metabolism |
18:35 | |
| |
| Releases Energy from Oxidation of Organic Molecules |
18:44 | |
| |
End Products of Fermentation |
19:05 | |
| |
| Ethanol, Acetic Acid, Lactic Acid |
19:22 | |
| |
| Propionin Acid and Carbon Dioxide, Acetone, Glycerol, Citric Acid, Sorbose |
20:02 | |
| |
Example 1 |
20:29 | |
| |
Example 2 |
21:43 | |
| |
Example 3 |
22:55 | |
|
Bacterial Infection Patterns |
41:12 |
| |
Intro |
0:00 | |
| |
'Hunting the Nightmare Bacteria' |
0:42 | |
| |
Classification of Bacteria |
2:13 | |
| |
Bacterial Pathogenesis |
2:31 | |
| |
| First Type of Immunity: Innate Immune System |
2:49 | |
| |
| Complement System |
3:00 | |
| |
| Innate Immune Cells: Phagocytosis |
3:10 | |
| |
| Cytokine Production and Epitopes |
3:29 | |
| |
Location of Bacteria Infections |
4:05 | |
| |
Steps of Bacterial Infection |
5:25 | |
| |
| Entry Into Host |
5:30 | |
| |
| Adherence to Host Tissue |
5:53 | |
| |
| Colonization |
5:58 | |
| |
| Overcome a Host's Defense |
6:02 | |
| |
| Hosts' Immune Response |
6:10 | |
| |
| Damage the Host Tissues |
6:17 | |
| |
| Progression or Recovery |
6:25 | |
| |
Portals of Entry |
6:35 | |
| |
The Skin |
7:18 | |
| |
Viral and Bacterial Infection of Respiratory |
7:46 | |
| |
| Bacteria Entry |
8:00 | |
| |
| Some Bacteria Produce Toxins and Enzymes |
8:28 | |
| |
| Immune Response is Disease Causing Part of Bacterial Infection |
8:46 | |
| |
Infection of Intestinal Epithelium |
8:59 | |
| |
| Shigella |
9:00 | |
| |
| Salmonella |
10:16 | |
| |
Numbers of Invading Bacteria |
11:05 | |
| |
| Virulence |
11:30 | |
| |
| Potency |
12:07 | |
| |
Virulence of Bacillus Anthracis |
12:33 | |
| |
Adherence of Bacteria to Host Tissue |
13:49 | |
| |
| Adhesins or Ligands |
14:10 | |
| |
| Glycocalyx |
14:26 | |
| |
| Fimbriae |
14:32 | |
| |
| M Protein |
14:53 | |
| |
Adherence |
15:07 | |
| |
| Adhesins or Ligands |
15:10 | |
| |
| E. coli Bacteria |
15:53 | |
| |
| Bacteria Adhering to Human Skin |
16:17 | |
| |
Group A Beta-Hemolytic Streptococci |
16:28 | |
| |
Bacterial Penetration of Host Defenses |
16:42 | |
| |
| Capsules |
16:57 | |
| |
| Cell Wall Components |
17:03 | |
| |
| Enzymes |
17:18 | |
| |
| Antigenic Variation |
17:27 | |
| |
| Penetration into Host Cell Cytoskeleton |
17:57 | |
| |
Capsules |
18:06 | |
| |
| Capsule |
18:07 | |
| |
| Glycocalyx |
18:19 | |
| |
| Functions to Impair Phagocytosis |
18:58 | |
| |
| Host Can However Develop Antibodies Against the Capsule |
19:07 | |
| |
Streptococcus Pneumoniae |
19:28 | |
| |
Cell Wall Components |
20:06 | |
| |
| M Protein |
20:18 | |
| |
| Neisseria Gonorrhea |
20:49 | |
| |
| Fimbriae |
20:57 | |
| |
Bacterial Enzymes |
21:23 | |
| |
| Coagulase |
22:08 | |
| |
| Hyalurpnidase |
22:09 | |
| |
| Collagenase |
22:13 | |
| |
| IgA Proteases |
22:19 | |
| |
Penetration |
22:44 | |
| |
| Invasins |
22:59 | |
| |
| Invasins Cause Host Cell Membrane to Ruffle |
23:12 | |
| |
| Shigella and Listeria |
23:32 | |
| |
Bacterial Damage to Host Cells |
23:50 | |
| |
| Production of Toxins |
24:11 | |
| |
| Types of Toxins |
24:56 | |
| |
Production of Toxins |
25:00 | |
| |
| Toxin |
25:08 | |
| |
| Toxigenicity |
25:21 | |
| |
| Toxemia |
25:25 | |
| |
| Toxoid |
25:30 | |
| |
| Antitoxin |
25:38 | |
| |
Exotoxin |
25:44 | |
| |
| Produced Inside Some Bacteria |
25:55 | |
| |
| Released When Bacteria Undergoes Lysis |
26:06 | |
| |
| Proteins and Enzymes That Catalyze Certain Biochemical Reactions |
26:39 | |
| |
| Bacteria That Produce Exotoxins Can be Gram + or Gram - |
26:53 | |
| |
| Exotoxins Are Soluble in Body Fluids |
27:04 | |
| |
| Some Diseases Caused by Their Exotoxins |
27:13 | |
| |
Exotoxin Examples |
27:35 | |
| |
Action of A-B Exotoxin |
28:11 | |
| |
Endotoxin |
29:12 | |
| |
| Endotoxin Differ from Extoxin in Several Ways |
29:21 | |
| |
| Endotoxins are Released When Gram - is Liberated |
30:24 | |
| |
| Antibiotics Used to Treat Gem |
30:32 | |
| |
| Endotoxins Stimulate Macrophages to Release High Concentrations of Cytokines |
30:59 | |
| |
Endotoxins and the Pyrogenic Response |
31:17 | |
| |
Example Endotoxins |
32:08 | |
| |
| Salmonella Typhi |
32:15 | |
| |
| Neisseria Meningitidis |
32:22 | |
| |
| Proteus Spp |
32:35 | |
| |
Steps of Bacterial Infection |
32:42 | |
| |
Bacterial Penetration of Host Defenses |
33:59 | |
| |
Example 1 |
34:41 | |
| |
Example 2 |
37:25 | |
| |
Example 3 |
39:39 | |
|
Bacterial Adaptation to Environment |
20:50 |
| |
Intro |
0:00 | |
| |
Bacterial Adaptation |
0:13 | |
| |
| Varied Tissues Within Human Host |
0:36 | |
| |
| Variable Levels of Oxygenation Both Inside and Outside of Host |
0:54 | |
| |
| Variable Levels of Moisture Both Inside and Outside Host |
1:10 | |
| |
| Survive Various Antibiotic and Other Types of Treatment |
1:23 | |
| |
Variable Oxygen Environments |
1:58 | |
| |
Bacterial Endospores |
3:33 | |
| |
| Clostridium Botulinum |
4:40 | |
| |
| Bacillus Anthracis |
4:48 | |
| |
| Clostridium Tetani |
4:50 | |
| |
Botulism: Neurotoxin |
5:10 | |
| |
Clostridium Botulinum |
6:29 | |
| |
| Gram Positive Rod-Shaped Bacteria That are Strictly Anaerobic |
6:58 | |
| |
| Produce Spores |
7:10 | |
| |
| Produces Paralysis |
7:49 | |
| |
| Toxin Can be Destroyed by Heating Food to 80 Degrees Celsius |
7:55 | |
| |
Bacillus Anthracis |
8:47 | |
| |
| Produce Spores |
9:08 | |
| |
| Anthrax is Mostly a Disease of Herbivores |
9:20 | |
| |
| Weaponized Anthrax is Primarily Inhalation Form |
10:11 | |
| |
Clostridium Tetani |
11:50 | |
| |
| Spores are Located in Solid and Can Colonize Gastrointestinal Tracts |
12:14 | |
| |
| Disease Uncommon |
12:27 | |
| |
| Toxin Produced During Growth Phase of Bacteria When Cell is Lysed |
13:14 | |
| |
| Toxin Blocks Release of GABA |
13:56 | |
| |
| Results in Paralysis |
14:09 | |
| |
Example 1 |
15:38 | |
| |
Example 2 |
16:45 | |
| |
Example 3 |
18:01 | |
|
Antigenic Composition of Bacteria |
33:08 |
| |
Intro |
0:00 | |
| |
Bacteria as Antigens |
1:04 | |
| |
| Antigen-antibody Interaction |
1:12 | |
| |
| Bacterial Adaptations as Antigens |
1:31 | |
| |
| Cell Wall Components |
1:44 | |
| |
| Capsules as Antigens |
1:50 | |
| |
| Flagella as Antigens |
1:58 | |
| |
| Antigenic Variation |
2:00 | |
| |
| Bacterial Antigenicity and Vaccines |
2:13 | |
| |
Antigen-Antibody Interaction |
2:20 | |
| |
| What are Antigens |
2:25 | |
| |
| Examples of Antigens |
3:09 | |
| |
Bacteria as Antigens |
4:33 | |
| |
| Adaptation to the Human Host Environment |
5:09 | |
| |
| Pathogenic Agent |
5:30 | |
| |
| Criteria for Effective Antigenicity |
6:02 | |
| |
Bacterial Adaptations That are Antigenic |
7:36 | |
| |
| Pila |
7:45 | |
| |
| Flagella as Antigens |
7:57 | |
| |
| Fimbriae |
7:59 | |
| |
| Capsules as Antigens |
8:22 | |
| |
| Peptidoglycan |
8:33 | |
| |
| S Proteins |
8:45 | |
| |
| M Protein and Lipid A |
9:09 | |
| |
Cell Wall Components |
9:47 | |
| |
| Neisseria Gonorrhea |
9:52 | |
| |
| Fimbriae and Opa |
10:03 | |
| |
| After Attachment, Host Cell Takes Bacteria |
10:22 | |
| |
| Secretory Antibodies |
10:38 | |
| |
| Circulating Antibodies |
10:58 | |
| |
| Capsule |
11:33 | |
| |
| Neutralize the Virulence |
12:39 | |
| |
Bacterial Capsules as Antigens |
13:20 | |
| |
| S. Pneumoniae |
13:55 | |
| |
| B. Anthracis |
14:09 | |
| |
| S. Pyogenes |
14:38 | |
| |
Bacterial Antigenicity |
15:30 | |
| |
| Motility and Vibrio Cholerae |
16:11 | |
| |
| Flagella are Antigenic |
16:20 | |
| |
| Agglutinate or Immobilize Bacterial Cells |
17:00 | |
| |
Antigenic Variation |
17:49 | |
| |
Antigenic Variation Over Time |
18:54 | |
| |
Antigenic Variation by Space and Time |
22:12 | |
| |
Bacterial Antigenicity and Vaccines |
24:02 | |
| |
Example 1 |
27:36 | |
| |
Example 2 |
31:24 | |
Section 7: Epidemiology of Infectious Diseases |
|
Epidemiology of Infectious Disease |
15:43 |
| |
Intro |
0:00 | |
| |
Infectious Diseases: Extent of Problem |
0:43 | |
| |
| 26% of Deaths Worldwide |
1:21 | |
| |
| Ebola Outbreak in Africa |
1:50 | |
| |
| Cholera in Haiti and South America |
2:22 | |
| |
| West Nile Virus Infections in U.S. |
2:39 | |
| |
Worldwide Cholera Occurrence |
3:03 | |
| |
Extent of Research |
4:38 | |
| |
Importance to National Security |
5:42 | |
| |
Bioterrorism Key Achievements |
7:00 | |
| |
| Smallpox |
7:06 | |
| |
| Anthrax |
7:22 | |
| |
| Botulinum |
7:28 | |
| |
| Ebola |
7:52 | |
| |
Importance of Epidemiology |
8:38 | |
| |
| Scientific Study of Causes and Determinants of Disease |
8:44 | |
| |
| Study of Vector and Animal Host Biology |
8:56 | |
| |
| Patterns of Disease Transmission |
9:39 | |
| |
| Determine Disease Causation |
10:31 | |
| |
| Development of Vaccines |
11:04 | |
| |
| Development and Evaluation of Effective Treatments |
11:55 | |
| |
Example 1 |
12:28 | |
|
Human Host & Disease Transmission |
56:19 |
| |
Intro |
0:00 | |
| |
Human Host and Disease Transmission |
0:19 | |
| |
| Discuss the Basis of Human Disease |
0:27 | |
| |
| Non-random Distribution of Disease |
0:34 | |
| |
| Ways Disease are Transmitted |
0:44 | |
| |
| Occurrence of Disease |
1:09 | |
| |
| Measures of Disease Transmission |
1:19 | |
| |
| Disease Outbreaks |
1:23 | |
| |
Basis of Human Disease |
1:39 | |
| |
| How Human Disease Arise |
1:43 | |
| |
| Host Must be Susceptible |
2:08 | |
| |
| Capacity to Infect |
2:32 | |
| |
| Environment |
2:53 | |
| |
Non-Random Distribution of Disease |
3:27 | |
| |
| Genetic Predisposition |
3:34 | |
| |
| Nutrition |
4:16 | |
| |
| Immune Status |
4:24 | |
| |
| Socio-Economic Status |
4:40 | |
| |
Modes of Disease Transmission |
5:46 | |
| |
| Direct Transmission |
5:54 | |
| |
| Indirect Transmission |
6:50 | |
| |
Example of Disease Transmission |
8:30 | |
| |
| HIV/ AIDS |
8:34 | |
| |
| Hepatitis A,B,C |
10:10 | |
| |
Clinical and Subclinical Disease |
12:42 | |
| |
| Clinical Disease |
12:49 | |
| |
| Subclinical Disease |
13:10 | |
| |
| Non Clinical Disease |
15:36 | |
| |
| Carrier Status |
17:48 | |
| |
| Carrier Status Example: Typhoid Mary |
18:33 | |
| |
Occurrence of Disease |
20:18 | |
| |
| Endemic |
20:27 | |
| |
| Epidemic |
21:30 | |
| |
| Pandemic |
21:45 | |
| |
Epidemic of Obesity |
22:22 | |
| |
Measures of Infectious Disease Transmission |
23:45 | |
| |
| Incubation Period |
24:23 | |
| |
| Epidemic Curve |
27:44 | |
| |
Disease Outbreaks |
28:37 | |
| |
| One Exposure, Common Vehicle |
28:43 | |
| |
| Outbreak Analysis |
32:14 | |
| |
Food Borne Illness |
34:06 | |
| |
| 76 Million Cases of Food Borne Illness Per Year |
34:07 | |
| |
| Known Pathogens |
35:08 | |
| |
| 62 Million Cases from Unknown Agents |
35:23 | |
| |
Example of Food Outbreak: Salmonella Saintpaul, 2008 |
35:34 | |
| |
Distribution of Outbreak Strain of Salmonella Found on Tomatoes and/or Jalapeno Peppers |
36:21 | |
| |
Number of Persons Infected with Salmonella Saintpaul |
38:10 | |
| |
Clinical Features of Salmonella Infection |
40:47 | |
| |
| Diarrhea |
41:06 | |
| |
| Abdominal Cramps |
41:11 | |
| |
| Identified by Stool Sample Culture |
41:19 | |
| |
| Severe Infection |
41:50 | |
| |
Case-Control Studies of Salmonella Saintpaul Infection |
42:26 | |
| |
Description of Outbreak Source Investigation |
45:02 | |
| |
Example 1 |
46:25 | |
| |
Example 2 |
50:43 | |
| |
Example 3 |
53:13 | |
|
Difference Measures of Disease |
39:23 |
| |
Intro |
0:00 | |
| |
Introduction |
0:16 | |
| |
| What is the Extent of Disease? |
1:00 | |
| |
| Who is at Risk for the Disease? |
1:07 | |
| |
| How is Disease Transmitted? |
1:36 | |
| |
| How is Disease Defined? |
1:52 | |
| |
Counts |
2:17 | |
| |
| Assessment |
2:32 | |
| |
| Example of Tuberculosis Count |
3:04 | |
| |
Counts of Influenza Positive Tests |
4:02 | |
| |
Counts of AIDS Cases |
5:58 | |
| |
Example of a Food Outbreak Investigation |
8:01 | |
| |
| Steps Public Health Investigators Follow to Determine Cause of Illness |
8:24 | |
| |
| Identifying the Source |
8:39 | |
| |
| Example |
9:04 | |
| |
Potential Sources of Contamination |
9:44 | |
| |
| Production |
9:55 | |
| |
| Farms |
10:14 | |
| |
| Distribution |
10:31 | |
| |
| Retail Establishments |
10:39 | |
| |
| Restaurant Example |
10:56 | |
| |
Food Borne Outbreak Investigation Steps |
11:43 | |
| |
| Determining if an Outbreak is Occurring |
11:57 | |
| |
| Defining Signs and Symptoms |
12:07 | |
| |
| Hypothesis |
12:14 | |
| |
| Collect Data and Test Hypothesis |
12:38 | |
| |
| Not Finding Associations |
13:09 | |
| |
| After Finding Pathogen, You Can Conduct Intervention to Remove Contaminated Food |
13:45 | |
| |
| Determine the Source |
14:09 | |
| |
| Clear Outbreak When All Contamination is Gone |
14:30 | |
| |
Case Study: Norovirus Outbreak Michigan Jan-Feb, 2006 |
14:34 | |
| |
Norovirus |
16:14 | |
| |
| Infects All Ages |
16:40 | |
| |
| Cause Infection Throughout the Year But There's a Peak in Time |
16:44 | |
| |
| Recognizing Outbreaks of Norovisur Infection |
16:51 | |
| |
Cases of Norovirus Over Time |
18:42 | |
| |
Attack Rate |
19:24 | |
| |
| Definition |
19:37 | |
| |
| Restaurant Example |
21:11 | |
| |
Attack Rate by 3 Hour Time Intervals |
22:52 | |
| |
Patrons Who Became Ill |
23:35 | |
| |
Case Control Analysis to Determine Food Source |
24:21 | |
| |
Attack Rate |
25:58 | |
| |
Food Outbreak Measures |
26:16 | |
| |
| Compute the Denominator |
27:06 | |
| |
| Compute Attack Rate During Certain Time Period |
27:28 | |
| |
| Construct Possible Hypotheses |
28:14 | |
| |
| Conduct Case-Control Analysis with Odds Ratio |
29:37 | |
| |
Example 1 |
29:47 | |
| |
Example 2 |
34:55 | |
| |
Example 3 |
36:51 | |
Section 8: Eukaryotes-structure, Function, Diversity, and Environmental Niche |
|
Eukaryotic Microbes |
20:53 |
| |
Intro |
0:00 | |
| |
Introduction to Eukaryotic Microbes |
0:38 | |
| |
| Helminths |
0:57 | |
| |
| Why are They Called Microorganisms |
1:01 | |
| |
| Parasites |
1:25 | |
| |
Introduction to Cell Theory |
2:03 | |
| |
Evolution of Multi-Cellularity |
3:30 | |
| |
| Prokaryotes Can Form into Colonies and Biofilms |
3:42 | |
| |
| Eukaryotic Cells Can Arrange Themselves Into Tissue |
3:58 | |
| |
| Multicellularity Evolved |
5:03 | |
| |
| Fossils of Bangiomorpha Pubescens |
5:45 | |
| |
| Timeline |
6:45 | |
| |
Endosymbiosis |
8:00 | |
| |
| Ancestral Anaerobic Eukaryote |
8:05 | |
| |
| Aerobic Eukaryote |
8:38 | |
| |
| Photosynthetic Cyanobacterium |
8:54 | |
| |
| Photosynthetic Eukaryote |
8:58 | |
| |
Phylogeny |
9:24 | |
| |
| Prokaryotes |
9:34 | |
| |
| Eukaryotes |
9:39 | |
| |
Organization of Eukaryotic Cell |
9:50 | |
| |
| Level 1: Monomeric Units |
10:13 | |
| |
| Level 2: Macromolecules |
10:16 | |
| |
| Level 3: Supramolecular Complexes |
10:37 | |
| |
| Level 4: The Cell and Its Organelles |
10:40 | |
| |
Eukaryotic Animal Cell |
11:01 | |
| |
| Nuclear Envelope |
11:53 | |
| |
| Plasma Membrane |
11:58 | |
| |
| Mitochondrion |
12:15 | |
| |
| Rough Endoplasmic Reticulum |
12:23 | |
| |
| Ribosomes |
12:51 | |
| |
| Peroxisomes |
13:00 | |
| |
| Cytoskeleton |
13:05 | |
| |
| Lysosome |
13:23 | |
| |
| Golgi Complex Processes |
13:27 | |
| |
| Smooth Endoplasmic Reticulum |
13:40 | |
| |
Eukaryotic Plant Cell |
14:01 | |
| |
| Cell Wall |
14:29 | |
| |
| Chloroplast |
14:49 | |
| |
| Starch Granule |
15:06 | |
| |
| Thylakoids |
15:17 | |
| |
| Golgi Complex, Cytoskeleton, Ribosomes |
15:25 | |
| |
| Nucleus, Smooth Endoplasmic Reticulum, Nucleolus |
15:33 | |
| |
| Mitochondrion |
15:39 | |
| |
Example 1 |
15:56 | |
| |
Example 2 |
18:44 | |
|
Eukaryotes: Fungi, Part I |
19:45 |
| |
Intro |
0:00 | |
| |
Introduction to Fungi |
0:15 | |
| |
| 1.5 Million Different Species on Earth |
0:17 | |
| |
| Fungal Diseases |
1:10 | |
| |
| Fungi Live Outdoors and Indoors |
1:17 | |
| |
| Most Fungi Are Not Dangerous |
1:30 | |
| |
Medically Important Fungi |
1:38 | |
| |
| Contagious Diseases |
1:40 | |
| |
| Commensal Organisms |
2:39 | |
| |
Fungal Growth |
3:14 | |
| |
| Vegetative Growth |
3:36 | |
| |
| Septate Hypha |
3:43 | |
| |
| Continuous Hyphae |
3:52 | |
| |
| Spore |
3:58 | |
| |
Fungal Dimorphism |
4:06 | |
| |
Fungi Life Cycle |
4:44 | |
| |
| Filamentous Fungi |
4:49 | |
| |
| Fungal Spores |
5:21 | |
| |
Fungal Fragmentation |
6:05 | |
| |
Fungal Spore Formation |
6:29 | |
| |
Fungi Sexual Reproduction |
6:57 | |
| |
| Plasmogamy |
7:06 | |
| |
| Karyogamy |
7:10 | |
| |
| Meiosis |
7:11 | |
| |
Sexual Spores |
7:45 | |
| |
| Ascospore |
8:11 | |
| |
Life Cycle of Ascomycete |
8:21 | |
| |
Histoplasmosis Capsulatum (Ascomycete) |
9:18 | |
| |
Histoplasmosis Distribution |
10:54 | |
| |
Histoplasmosis Lifecycle |
11:28 | |
| |
Fungal Diseases |
13:06 | |
| |
| Mycosis |
13:08 | |
| |
| Chronic and Long Term |
13:16 | |
| |
| Five Groups |
13:21 | |
| |
| Systemic |
13:30 | |
| |
| Subcutaneous |
13:37 | |
| |
| Cutaneous |
13:40 | |
| |
| Superficial |
13:42 | |
| |
| Opportunistic |
13:45 | |
| |
Example 1 |
14:18 | |
| |
Example 2 |
17:40 | |
|
Eukaryotes: Fungi, Part II |
31:55 |
| |
Intro |
0:00 | |
| |
Introduction to Fungi |
0:19 | |
| |
| Recap of Fungi Part One |
0:20 | |
| |
| 1.5 Million Species |
0:28 | |
| |
| Focus on Fungi That Cause Human Disease |
0:59 | |
| |
Medically Important Fungi |
1:42 | |
| |
| Contagious Diseases? |
1:44 | |
| |
| Dermatophytosis Example |
2:02 | |
| |
| Pneumocystis Example |
2:22 | |
| |
| Commensal Organisms: Candida Albicans |
2:36 | |
| |
Fungal Diseases |
3:02 | |
| |
| Mycosis |
3:06 | |
| |
| Fungal Mycoses |
3:12 | |
| |
| Five Groups |
3:22 | |
| |
Superficial Fungal Diseases |
4:10 | |
| |
| Fungi That are Localized in Hair Shafts and on Skin Surface |
4:20 | |
| |
| Prevalent in Tropical Climate |
4:31 | |
| |
| Benign |
4:38 | |
| |
| Figures Explanation |
4:44 | |
| |
Cutaneous Fungal Disease |
5:04 | |
| |
| Infect the Epidermis |
5:05 | |
| |
| Dermatomycoses |
5:21 | |
| |
| Dermatophytes |
5:31 | |
| |
| Dermatophytes Secrete Keratinase |
6:04 | |
| |
| Examples |
6:31 | |
| |
Subcutaneous Fungal Diseases |
6:39 | |
| |
| Fungal Infections Beneath the Skin |
6:42 | |
| |
| Occur After a Puncture Wound |
6:58 | |
| |
| Infections Occur Among Farmers |
8:15 | |
| |
| Example: Sporotrichosis |
8:26 | |
| |
Candidiasis Albicans |
8:57 | |
| |
| Most Common in Yeast Infections |
8:58 | |
| |
| Resides on Skin Surfaces |
9:16 | |
| |
| Resistant to Phagocytosis |
9:46 | |
| |
Opportunistic Fungal Disease |
12:25 | |
| |
| Host is Debilitated or Traumatized |
12:52 | |
| |
| Under Treatment with Broad Spectrum Antibiotics |
13:20 | |
| |
| Immune System is Suppressed by Drugs |
14:03 | |
| |
| Has an Immune Disorder or Lung Disease |
14:19 | |
| |
Pneumocystis Pneumonia |
14:47 | |
| |
| Caused by Pneumocystis Jirovecii |
14:56 | |
| |
| Most Frequent and Severe Opportunistic Infection |
15:05 | |
| |
| Immunocompetent Adults Have Few or No Symptoms |
15:59 | |
| |
| Example: Pneumocystis Cysts in Lung of Patient with AIDS |
16:58 | |
| |
Life Cycle of Pheumocystis Jirovecii |
17:34 | |
| |
Early Incidence of Pneumocystis |
18:49 | |
| |
Systemic Fungal Disease |
21:21 | |
| |
| Fungal Infections Deep Within the Body |
21:24 | |
| |
| Caused by Fungi Living in the Soil |
21:44 | |
| |
| Infections Begin in Lungs and Spread to Other Tissue |
22:13 | |
| |
| Example: Coccidiodomycosis Infection of Lung Tissue |
22:21 | |
| |
Life Cycle of Coccidiodes Immitis |
23:12 | |
| |
Number of Coccidiomycosis Cases |
24:10 | |
| |
Distribution of Coccidiomycosis Cases |
26:06 | |
| |
Example 1 |
27:20 | |
| |
Example 2 |
30:08 | |
|
Parasites |
20:01 |
| |
Intro |
0:00 | |
| |
Introduction to Parasites |
0:48 | |
| |
| Live in Human Hosts |
1:00 | |
| |
| Example of Parasites |
1:29 | |
| |
Extent of Parasitic Diseases |
1:47 | |
| |
| Parasitic Infections Cause a Tremendous Burden of Disease |
1:54 | |
| |
| Malaria Example |
2:12 | |
| |
| Neglected Tropical Diseases |
2:38 | |
| |
Extent of Malaria |
3:22 | |
| |
Relationships Between Species |
6:51 | |
| |
Symbiosis Between Pathogen and Host |
7:11 | |
| |
| Symbiosis |
7:29 | |
| |
| Mutualism |
7:58 | |
| |
| Commensalism |
8:05 | |
| |
| Parasitism |
9:10 | |
| |
Parasite Definitions |
9:28 | |
| |
| Parasite Definition |
9:32 | |
| |
| Three Major Classes |
9:54 | |
| |
Ectoparasites |
10:15 | |
| |
Locations of Parasitic Infection |
10:48 | |
| |
Parasite Hosts and Vectors |
12:21 | |
| |
| Vectors Convey a Parasite from Host to Host |
12:27 | |
| |
| Anopheles Mosquito and Malaria |
12:43 | |
| |
Example 1 |
13:04 | |
| |
Example 2 |
15:34 | |
|
Eukaryotes: Protozoa |
24:59 |
| |
Intro |
0:00 | |
| |
Introduction to Protozoa |
0:13 | |
| |
| Protozoa Definition |
0:14 | |
| |
| Intestinal Protozoa |
1:19 | |
| |
| Insect Vectors |
1:47 | |
| |
Transmission of Enteric Protozoa |
2:02 | |
| |
Transmission of Blood Borne Protozoa: Leishmaniasis |
4:50 | |
| |
| Leishmaniasis Transmission Chart |
5:33 | |
| |
| Cutaneous Leishmaniasis |
7:15 | |
| |
| Visceral Leishmaniasis |
7:37 | |
| |
Medically Important Protozoa |
8:07 | |
| |
| Four Classes |
8:24 | |
| |
| Described by the Systems They Infect |
8:54 | |
| |
Flagellates |
9:10 | |
| |
| Intestinal and Genito-Urinary Flagellates |
9:32 | |
| |
| Blood and Tissue Flagellates |
9:42 | |
| |
Ambae |
10:45 | |
| |
| Typically Amoeboid |
10:49 | |
| |
| Represented by Entamoeba, Negleria, and Acanthamoeba |
11:27 | |
| |
Sporozoa |
12:38 | |
| |
| Alternating Sexual and Asexual Reproductive Phases |
12:56 | |
| |
| Cyclospora Life Stage |
13:13 | |
| |
Lifecycle of Sporozoa: Cryptosporidium |
16:16 | |
| |
Ciliates |
17:20 | |
| |
| Complex Protozoa Bearing Cilia Distributed in Rows or Patches with Two Kinds of Nuclei in Each Cell |
17:24 | |
| |
| Balantidium Coli |
17:54 | |
| |
Example 1 |
20:06 | |
| |
Example 2 |
22:52 | |
|
Eukaryotes: Helminths |
32:53 |
| |
Intro |
0:00 | |
| |
Introduction to Helminths |
0:30 | |
| |
| Definition of Helminths |
0:31 | |
| |
| Three Types of Helminths |
0:54 | |
| |
Biological Properties of Helminths |
1:38 | |
| |
| Biological Life Cycle of Helminths |
1:42 | |
| |
| Adult Helminths May Be Dioecious |
3:25 | |
| |
| Monoecious Helminths |
3:58 | |
| |
Characteristics of Helminths |
4:12 | |
| |
| May Lack a Digestive System |
4:16 | |
| |
| Nervous System is Reduced |
4:41 | |
| |
Incidence of Helminth Infections Worldwide |
5:50 | |
| |
Intestinal Helminths |
6:29 | |
| |
Soil Transmitted Helminths |
8:15 | |
| |
Wuchereria Bancrofti |
8:35 | |
| |
| Wuchereria Bancrofti Causes Lymphatic Filariasis |
9:01 | |
| |
| Nematode or Roundword That Inhibits Lymphatic Vessels |
9:18 | |
| |
| Life Cycle |
9:43 | |
| |
Lifecycle of Wuchereria Bancrofti |
10:11 | |
| |
Symptoms of Wuchereria Bancrofti |
11:41 | |
| |
| Elephantiasis |
11:59 | |
| |
| People Who Develop Lymphedema |
12:39 | |
| |
Types of Chronic Tissue Helminth Infection |
14:53 | |
| |
Distribution of Lymphatic Filariasis in India |
18:08 | |
| |
Taenia Saginata or Solium |
19:19 | |
| |
| Human Tapeworms |
19:20 | |
| |
| Cestode That Inhabits Intestinal Tracts of Human Hosts |
19:36 | |
| |
| Taenia |
20:01 | |
| |
| Scolex |
20:53 | |
| |
Tania or Tapeworms |
21:39 | |
| |
Life Cycle of Taenia Saginata or Solium |
22:15 | |
| |
Urban Myth of Reality |
24:35 | |
| |
Example 1 |
25:41 | |
| |
Example 2 |
28:38 | |
|
Helminths & Immunity |
32:50 |
| |
Intro |
0:00 | |
| |
The Immune System |
0:45 | |
| |
| Innate Immune Response |
1:04 | |
| |
| Adaptive Immune Response |
1:15 | |
| |
Autoimmunity and Helminth Infection |
2:20 | |
| |
| Endemic Type 1 Diabetes |
2:26 | |
| |
| Endemic Helminth Infections |
2:47 | |
| |
Coevolution of Helminths and Immunity |
4:43 | |
| |
| Helminth Infections are a Driving Force in Shaping |
5:53 | |
| |
| Helminths Do Not Replicate in Human Host |
6:37 | |
| |
| Helminths are Able to Maintain a Co-existence With Immune System |
7:18 | |
| |
| Innate Immunity |
7:46 | |
| |
| Adaptive Immunity |
7:52 | |
| |
Localized Impact of Helminth Infection |
9:05 | |
| |
Immune Modulation of Helminth Infection |
14:07 | |
| |
Helminths and Immune Response |
15:55 | |
| |
| Other Ways Helminths Facilitate Immune Response |
17:45 | |
| |
Helminth Influence on Immunity |
19:07 | |
| |
Types of Chronic Tissue Helminth Infection |
22:04 | |
| |
| Infected, Low Pathology - Develop Tolerance |
22:35 | |
| |
| Chronic Pathology |
22:50 | |
| |
Pathogen Co-Existence and Immunity |
23:29 | |
| |
Helminths and Autoimmunity in Mice |
25:31 | |
| |
Summary of Helminths and Immunity |
26:39 | |
| |
| Hygiene Hypothesis |
26:42 | |
| |
| Driving Force in Shaping |
27:27 | |
| |
| Absence of Helminths and the Immune Tolerances |
27:46 | |
| |
Example 1 |
28:10 | |
| |
Example 2 |
30:23 | |
Section 9: Survey of Important Bacteria |
|
Gram Positive Bacteria |
46:35 |
| |
Intro |
0:00 | |
| |
Introduction |
1:01 | |
| |
| External Peptidoglycan |
1:07 | |
| |
| Stain Purple |
1:16 | |
| |
| Reasons How External Peptidoglycan is Important |
1:30 | |
| |
Properties of Gram Positive Bacteria |
1:51 | |
| |
Immune Attack of Gram Positive Bacteria |
3:21 | |
| |
| Process of Opsonization |
3:29 | |
| |
| What is Opsonization |
3:39 | |
| |
| Complement Forms Membrane Attack Complexes |
4:38 | |
| |
| Ways Bacteria Gets Recognized by the System |
5:14 | |
| |
Properties of Gram Positive Bacteria |
6:55 | |
| |
| Metabolism |
7:00 | |
| |
| Survival Mechanisms |
7:11 | |
| |
| Shapes |
7:23 | |
| |
| Environments |
7:39 | |
| |
Examples of Gram Positive Bacteria |
7:59 | |
| |
Shapes of Gram Positive Bacteria |
9:13 | |
| |
| Streptococci vs. Staphylococci |
9:26 | |
| |
| Staphylococci Shape |
9:38 | |
| |
| Streptococci Shape |
9:52 | |
| |
Staphylococcus Bacteria |
10:04 | |
| |
| Staphylococcus |
10:20 | |
| |
| Salt-Tolerant |
11:36 | |
| |
| Two Main Species |
12:24 | |
| |
| Pathogenicity |
12:38 | |
| |
| Enzymes and Toxins |
13:38 | |
| |
Staphylococcus Aureus |
14:57 | |
| |
| Food Borne Infection |
15:04 | |
| |
| Skin Infections |
15:29 | |
| |
| Systemic Disease |
16:14 | |
| |
Staphylococcus Bacteria |
17:36 | |
| |
| Categorized According to Antigens |
18:00 | |
| |
| Streptococcus Group A |
18:09 | |
| |
Streptococcus Pyogenes |
19:09 | |
| |
| Pathogenicity |
19:37 | |
| |
| Rheumatic Fever |
20:00 | |
| |
| Necrotizing Fasciatis |
20:39 | |
| |
| Glomerulonephritis |
21:30 | |
| |
| Surface M Protein |
21:50 | |
| |
| Hyaluronic Acid Capsule |
22:25 | |
| |
| Enzymes |
22:47 | |
| |
| Pyrogenic Toxins |
22:57 | |
| |
Bacillus |
23:34 | |
| |
| Has Endospore Stage and Produces Toxins |
23:59 | |
| |
| Bacillus Anthracis |
24:16 | |
| |
| Spores Activated |
25:12 | |
| |
| Toxins Cause Disease |
25:40 | |
| |
Clostridium Bacteria |
26:02 | |
| |
| Gram Positive, Anaerobic, and Endospore Producing |
26:30 | |
| |
| Different Clostridium Bacteria |
26:56 | |
| |
Clostridium Difficile |
27:34 | |
| |
| Commonly Found Among the Intestinal Microbiota |
27:38 | |
| |
| Opportunistic Pathogen |
27:57 | |
| |
| Common in Hospital |
28:30 | |
| |
Age-Adjusted Death Rate for Enterocolitis Due to C. Difficile |
29:16 | |
| |
Listeria Bacteria |
29:54 | |
| |
Avoidance of Immune Reaction by Listeria |
31:23 | |
| |
Multi-State Listeriosis Outbreak from Whole Cantaloupes Grown by Jensen Farms, Colorado |
33:04 | |
| |
Example 1 |
36:17 | |
| |
Example 2 |
39:05 | |
| |
Example 3 |
43:47 | |
|
Gram Negative Bacteria |
44:38 |
| |
Intro |
0:00 | |
| |
Introduction |
0:29 | |
| |
| Internal Cell Wall |
0:45 | |
| |
| Characteristic Properties |
0:54 | |
| |
Gram Negative Bacterial Cell Wall |
2:01 | |
| |
| Outer Membrane Provides a Barrier |
3:05 | |
| |
| Outer Membrane Contains Lipid A |
3:16 | |
| |
Properties of Gram Negative Bacteria |
3:20 | |
| |
| Lipid A Molecule |
3:26 | |
| |
| Lipopolysaccharides |
3:40 | |
| |
| Most Gram Negative Bacteria Do Not Form Spores |
3:54 | |
| |
Gram Negative Laboratory Algorithm |
4:05 | |
| |
Properties of Gram Negative Bacteria |
6:45 | |
| |
| Outer Membrane |
6:50 | |
| |
| Genetic Exchange |
6:53 | |
| |
Immune Reaction to Gram Negative Bacteria |
7:49 | |
| |
Examples of Gram Negative Bacteria |
12:12 | |
| |
Endotoxin |
12:52 | |
| |
| Differ from Exotoxin in Several Ways |
13:05 | |
| |
| Released When Gram Negative Bacteria Undergo Lysis and Endotoxin is Liberated |
13:50 | |
| |
| Stimulate Macrophages to Release High Concentrations of Cytokines |
14:36 | |
| |
E. Coli Bacteria |
15:03 | |
| |
| Escherichia Coli |
15:06 | |
| |
| Pathogenic Strains of E. Coli |
15:28 | |
| |
Shiga-Toxin E. Coli Outbreak, Germany 2011 |
16:24 | |
| |
Salmonella Bacteria |
18:29 | |
| |
| Pathogenicity |
18:36 | |
| |
| Infection by Salmonella |
20:36 | |
| |
| Another Image of Infection by Salmonella |
21:41 | |
| |
Bacterial Infections, 2013 |
23:44 | |
| |
Vibrio Bacteria |
25:12 | |
| |
| Vibrio Genus |
25:37 | |
| |
| Most Virulent Species is Vibrio Cholerae |
25:50 | |
| |
Cholera Life Cycle |
26:59 | |
| |
Worldwide Cholera Cases |
29:44 | |
| |
New Cases of Cholera in Haiti During a 2 Year Period |
30:24 | |
| |
Preventing Cholera Infection with Gut Flora |
31:10 | |
| |
Bordetella Pertussis |
32:55 | |
| |
| Aerobic Coccobacillus |
33:24 | |
| |
| Tracheal Toxin |
33:40 | |
| |
| Pertussis Toxin |
33:50 | |
| |
Pertussis Infection Timeline |
34:25 | |
| |
Pertussis Symptom Timeline |
36:10 | |
| |
Reported Pertussis Cases in US 1922-2003 |
37:31 | |
| |
Example 1 |
38:09 | |
| |
Example 2 |
39:36 | |
| |
Example 3 |
41:16 | |
|
Bacteria with Other Cell Walls |
24:06 |
| |
Intro |
0:00 | |
| |
Bacteria Classification by Cell Wall |
0:21 | |
| |
| Gram Positive vs. Gram Negative |
1:01 | |
| |
| Gram Stain |
1:18 | |
| |
| Shape |
1:24 | |
| |
Bacteria Undetectable with Gram Stain |
3:07 | |
| |
| Mycobacteria |
3:23 | |
| |
| Mycoplasma Pneumonia |
4:02 | |
| |
| Chlamydia |
4:11 | |
| |
Mycoplasma Pneumoniae Bacteria |
4:23 | |
| |
| Atypical Small Bacterium Without A Cell Wall |
4:30 | |
| |
| Lacks Rigid Cell Wall |
5:02 | |
| |
| Extracellular in Respiratory Tract |
7:02 | |
| |
Acid-Fast Bacteria |
7:38 | |
| |
Mycobacterium Tuberculosis |
8:36 | |
| |
| Infectious Process |
10:31 | |
| |
Tuberculosis Incidence in 2005 |
12:45 | |
| |
Chlamydia Trachomatis Bacteria |
15:11 | |
| |
| Obligate Intracellular Human Parasite |
15:39 | |
| |
| Gram Negative |
16:01 | |
| |
| Three Human Biovars |
16:15 | |
| |
Life Cycle of Chlamydia |
17:33 | |
| |
Example 1 |
19:42 | |
| |
Example 2 |
21:01 | |
Section 10: Microbes and Human Disease |
|
Tuberculosis |
28:00 |
| |
Intro |
0:00 | |
| |
Tuberculosis Introduction |
0:47 | |
| |
| Malaria |
0:51 | |
| |
| Acid-Fast Staining |
1:04 | |
| |
| Tuberculosis Disease |
1:42 | |
| |
| Latent and Active Disease |
1:51 | |
| |
| Strong Man Image Example |
2:22 | |
| |
Mycobacterium Tuberculosis |
2:39 | |
| |
| Cell Wall |
2:48 | |
| |
Tuberculosis Incidence in 2012 |
3:21 | |
| |
Worldwide Tuberculosis Incidence |
4:19 | |
| |
TB Research Center, Chennai, India |
5:00 | |
| |
Tuberculosis in United States |
5:47 | |
| |
Estimated HIV Co-Infection Among Individuals Diagnosed with TB in U.S. |
6:28 | |
| |
Tuberculosis Pathogenesis |
7:40 | |
| |
| Infection |
7:50 | |
| |
| How It's Spread |
8:09 | |
| |
| What Determines Whether or Not an Individual Will be Exposed |
8:49 | |
| |
| Bacilli can Multiply Once Reaching the Alveoli |
9:21 | |
| |
Mycobacterium Tuberculosis |
10:18 | |
| |
| Inactive Form of TB |
10:34 | |
| |
| Active vs. Inactive Form of TB Depends on If Bacilli Stay in Tissue or Break Out |
10:44 | |
| |
Tuberculosis Pathogenesis |
11:20 | |
| |
| Bacilli That Reach Alveoli |
11:32 | |
| |
| Those Bacilli are Ingested by Macrophages |
12:28 | |
| |
| No Symptoms of Disease |
13:20 | |
| |
| More Advanced Stage |
13:25 | |
| |
| Multiply in Macrophages |
13:45 | |
| |
| Inflammation |
14:24 | |
| |
| After a Few Weeks Disease Symptoms Appear |
15:00 | |
| |
| Caseous Center |
15:30 | |
| |
| Aerobic Bacilli Do Not Grow Well in the Center |
16:18 | |
| |
| Granuloma Can Reactivate Later |
16:46 | |
| |
| Active Disease: The Granuloma Can Rupture with Liquefaction |
17:25 | |
| |
| Active TB |
18:04 | |
| |
Tuberculosis Staging |
18:12 | |
| |
| Stage 3 Important Stage |
18:40 | |
| |
| Stage 5 You Have TB |
18:55 | |
| |
Tuberculosis Testing |
19:31 | |
| |
| Tuberculin Skin Test |
19:32 | |
| |
| Positive Skin Reaction Image Example |
20:14 | |
| |
Tuberculosis Vaccination |
20:32 | |
| |
| BCG Vaccination in Other Areas Around the World |
20:48 | |
| |
| BCG Protects from the Active Form of Tuberculosis |
21:06 | |
| |
| BCG Does Not Confer Lifelong Protection |
22:34 | |
| |
Mycobacterium Tuberculosis |
22:51 | |
| |
| Target Different Parts |
23:09 | |
| |
| Regiment |
23:32 | |
| |
Example 1 |
24:34 | |
| |
Example 2 |
26:40 | |
|
Malaria, a Protozoan Disease |
29:59 |
| |
Intro |
0:00 | |
| |
Protozoa Introduction |
1:13 | |
| |
| One-Celled Organisms |
1:14 | |
| |
| Free Living or Parasitic |
1:19 | |
| |
| Can Multiply in Humans |
1:27 | |
| |
| How Does a Pathogen Get to the Digestive Tract |
1:44 | |
| |
Worldwide Cases of Malaria |
3:06 | |
| |
| Found Where There a Lot of Mosquitoes |
3:14 | |
| |
Malaria Introduction |
4:00 | |
| |
| Protozoa |
4:03 | |
| |
| Lives Partially in Human Host, Partially in Mosquito |
4:06 | |
| |
| Four Major Species |
4:29 | |
| |
| Carried by Anopheles Mosquitoes |
4:49 | |
| |
Lifecycle of Malaria |
5:08 | |
| |
| Two Stages in Human Host and One Stage in Mosquito |
5:30 | |
| |
| Mosquito Bites and Injects Sporozoites |
5:49 | |
| |
| Parasite Goes Into Liver |
7:14 | |
| |
| Blood Supply |
7:33 | |
| |
| Diagnostic Stage |
7:55 | |
| |
| Erythrocytes |
8:11 | |
| |
| Gametocytes |
9:04 | |
| |
| Final Stage: Release of Sporozoites |
9:39 | |
| |
Sickle Cell Anemia and Moleria |
10:16 | |
| |
| Sickle Cell Anemia is a Genetic Mutation Disease |
10:34 | |
| |
| Function |
11:05 | |
| |
| Hemoglobin Shape and Oxygen Capacity are Slightly Different |
11:16 | |
| |
Selective Advantages and Disadvantages |
12:04 | |
| |
| Effects at a Cellular Level |
12:06 | |
| |
| Effects at the Organismal Level |
12:39 | |
| |
| Effects at the Population Level |
12:54 | |
| |
Evolution of Human Malaria |
13:31 | |
| |
| Plasmodium Parasite Has Evolved |
13:40 | |
| |
| Plasmodium Reichenowi |
13:56 | |
| |
| What's Going on in India |
14:43 | |
| |
Malaria Pathogenicity |
15:40 | |
| |
| Incubation Period |
15:41 | |
| |
| Symptoms |
16:05 | |
| |
| P. vivax and P. ovale |
16:41 | |
| |
| Dormant Liver Stage |
16:57 | |
| |
| Diagnosis |
18:33 | |
| |
Malaria Treatment |
19:30 | |
| |
| Depends on Many Factors |
19:32 | |
| |
| Medications |
20:32 | |
| |
Example 1 |
22:28 | |
| |
Example 2 |
27:38 | |
|
HIV/AIDS |
38:07 |
| |
Intro |
0:00 | |
| |
What is HIV / AIDS? |
0:31 | |
| |
| Human Immunodeficiency Virus |
0:32 | |
| |
| Once Infected, the Virus Will Always Be There |
1:28 | |
| |
| Exception |
1:45 | |
| |
| Transmitted Through Body Fluids |
2:10 | |
| |
| Virus |
2:15 | |
| |
HIV Can be Transmitted Through |
3:13 | |
| |
| Sexual Contact, Injection Drug Use, Occupational Exposure, Pregnancy, Blood Transfusion |
3:14 | |
| |
| Blood Transfusion Used to be Significant for Disease Transmission |
3:31 | |
| |
Adult HIV Prevalence, 2012 |
4:30 | |
| |
| Africa is Highest |
4:40 | |
| |
| North and South America are Also High Prevalence |
4:44 | |
| |
| India |
5:02 | |
| |
Counts of AIDS Cases |
5:22 | |
| |
Example of Disease Transmission |
7:19 | |
| |
| Males |
7:31 | |
| |
| Females |
7:42 | |
| |
| HIV/ AIDS Methods of Transmission |
8:33 | |
| |
HIV Retrovirus |
9:10 | |
| |
| Retrovirus |
9:21 | |
| |
| Replicate the Virus |
10:13 | |
| |
Life Cycle of HIV Virus |
10:55 | |
| |
| Genome |
11:10 | |
| |
| Reverse Transcription |
11:16 | |
| |
| Host DNA Produces Goes Through Transcription and Translation |
11:26 | |
| |
| Produce Viral RNA |
11:36 | |
| |
| Importance of Figure |
12:00 | |
| |
Viral Load and Immune Cell |
12:45 | |
| |
| Individual Infected |
12:52 | |
| |
| Plasma Virus Load Increases then Rapidly Declines |
12:58 | |
| |
| CD4+ T Cell |
13:34 | |
| |
| Immune System is Suppressed Enough That AIDs Develops |
14:20 | |
| |
Evolution of HIV/ AIDS |
15:31 | |
| |
Immunodeficiency and Development of Opportunistic Infections |
17:40 | |
| |
| Herpes Simplex Virus |
18:00 | |
| |
| Herpes Zoster Ophthalmicus |
18:10 | |
| |
| Kaposi Sarcoma and Many More |
18:22 | |
| |
| Disease Emerge at Different Time Depending on Degree of Suppression |
18:40 | |
| |
Opportunistic Infections with HIV |
18:52 | |
| |
| Early 1900s |
19:04 | |
| |
| Pneumocystis |
19:21 | |
| |
Opportunistic Fungal Disease |
20:15 | |
| |
| Harmless, Opportunistic Fungi |
20:31 | |
| |
| Can Happen to Individuals Who are Taking Drugs to Suppress Immune System |
20:44 | |
| |
Pneumocystis Pneumonia |
21:13 | |
| |
| Pathogen |
21:32 | |
| |
| Immunodeficient Adults |
21:41 | |
| |
Estimated HIV Co-Infection Among Individuals Diagnosed with TB in U.S. |
22:00 | |
| |
Kaposi Sarcoma |
22:42 | |
| |
| Rare Cancer |
22:49 | |
| |
| Skin Neoplasm |
23:14 | |
| |
| Subtypes All Have Human Herpesvirus-8 |
23:31 | |
| |
| How It Looks |
23:57 | |
| |
| Kaposi Sarcoma Spindle Cells |
24:29 | |
| |
| How to Treat Kaposi Sarcoma |
25:17 | |
| |
HIV Prevalence Among Young Adult Women in India |
26:02 | |
| |
Example 1 |
31:24 | |
| |
Example 2 |
33:32 | |
|
Ebola |
43:09 |
| |
Intro |
0:00 | |
| |
Ebola Virus Overview |
0:22 | |
| |
Ebola Virus Outbreak Distribution |
0:59 | |
| |
| 1976 Ebola Outbreak First Identified |
1:00 | |
| |
| Recent Outbreak in Zaire |
2:15 | |
| |
| Three Countries Most Affected Today |
2:39 | |
| |
| Amount of Hospitals in Those Countries |
3:40 | |
| |
Ebola Virus Ecology |
4:14 | |
| |
| Thought to Just Infect Warm Blooded Animals |
4:24 | |
| |
| Epidemic Starts When Virus Infects Humans |
4:45 | |
| |
Ebola Virus Infection |
5:55 | |
| |
| Virus Comes From Animal and Infects Human |
5:57 | |
| |
| Infected Cells |
6:10 | |
| |
| Endothelial Cell Gaps Causes Leakage of Blood and Virus |
6:35 | |
| |
Ebola Virus Symptoms |
7:37 | |
| |
| Fever |
7:43 | |
| |
| Early Signs |
7:54 | |
| |
| Big Sign of Being Infected: Travel History |
8:18 | |
| |
| Key About the Symptom Emerging |
9:40 | |
| |
Timeline of Ebola Virus Symptoms |
11:21 | |
| |
| Day 2: First Symptoms |
11:36 | |
| |
| Day 10: High Fever and Vomiting |
12:29 | |
| |
| Day 11: Brain Damage and Bleeding |
13:13 | |
| |
| Day 12: Loss of Consciousness |
13:44 | |
| |
Ebola Virus Characteristics |
14:14 | |
| |
| Filovirus |
14:27 | |
| |
| Enveloped, Helical Viruses |
14:31 | |
| |
| Ebola and Marburg Viruses |
14:36 | |
| |
Morphology of Helical Ebola Virus |
14:52 | |
| |
| Capsid |
14:56 | |
| |
| Nucleic Acid |
15:04 | |
| |
Ebola Virus Structure |
15:38 | |
| |
| Outside of the Structure |
15:42 | |
| |
| Inside the Envelope |
15:56 | |
| |
| Virus Can Recreate Itself in the Cytoplasm |
16:54 | |
| |
RNA Viral Replication |
18:04 | |
| |
| Negative and Positive Strand |
18:32 | |
| |
Ebola Virus Entry |
20:26 | |
| |
| Cell the Virus Penetrates |
21:18 | |
| |
| Inflammatory Reaction |
21:45 | |
| |
| Viruses Released Into Individuals Body |
22:23 | |
| |
Ebola Virus: Immune Reaction |
23:08 | |
| |
| Survivors |
23:20 | |
| |
| Individuals Who Die From Ebola |
23:33 | |
| |
| Effective Dose |
24:03 | |
| |
Host Immune Response to Ebola |
24:36 | |
| |
| Monocyte |
24:44 | |
| |
| Cytokines Storm |
25:01 | |
| |
Ebola Virus Pathogenisis |
25:40 | |
| |
| Infection |
25:46 | |
| |
| Neutrophil |
25:56 | |
| |
| Depletion of Natural Killer Cells |
26:06 | |
| |
| Ebola Virus Can Serve to Surpress the Immune Reaction |
26:37 | |
| |
How Contagious is Ebola? |
27:49 | |
| |
| Not Very Contagious, But Very Infectious |
27:58 | |
| |
| In Relation to Other Diseases |
28:43 | |
| |
Ebola Transmission |
29:24 | |
| |
| Patient Zero Thought to be Infected by Animal |
29:28 | |
| |
| Eating Bushmeat In West Africa |
29:46 | |
| |
| Ebola Spreads by Direct Contact |
30:16 | |
| |
Ebola in Healthcare Settings |
31:13 | |
| |
| Healthcare Workers at Higher Risk Because They Handle Body Fluids |
31:22 | |
| |
| Precautions |
32:07 | |
| |
Treatment of Ebola |
34:13 | |
| |
| No Vaccine, but There Are Experimental Treatments (ZMAPP) |
34:18 | |
| |
| Basic Interventions When Done Early, Can Improve Chances of Survival |
36:27 | |
| |
Example 1 |
37:41 | |
| |
Example 2 |
39:18 | |
| |
Example 3 |
41:05 | |